TempP

Version vom 27. September 2020, 20:01 Uhr

cont as TempP(1)

32628145 2020. Blocking angiotensin earlier with RAS blockers, statins, and heparin in high-risk COVID-19 patients: Is the remedy here?
32634024 2020. How to Quantify and Interpret Treatment Effects in Comparative Clinical Studies of COVID-19.
32646061 2020. Could Ergothioneine Aid in the Treatment of Coronavirus Patients?
32638906 2020. Controle do Intervalo QT para Prevencao de Torsades de Pointes Durante uso de Hidroxicloroquina e/ou Azitromicina em Pacientes com COVID 19.
32645994 2020. Ten-Year Research Update Review: Antiviral Activities from Marine Organisms.
32649880 2020. Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in Weeks.
32641681 2020. Is hydroxychloroquine beneficial for COVID-19 patients?
32638908 2020. Double-edged sword: Granulocyte colony stimulating factors in cancer patients during the COVID-19 era.
32646869 2020. Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic.
32646499 2020. Effect of favipiravir and an anti-inflammatory strategy for COVID-19.
32631373 2020. Clarifying the controversial risk-benefit profile of soluble ACE2 in COVID-19.
32620147 2020. Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series.
32618691 2020. A Centrally Acting Antihypertensive, Clonidine, Sedates Patients Presenting With Acute Respiratory Distress Syndrome Evoked by Severe Acute Respiratory Syndrome-Coronavirus 2.
32640414 2020. Vitamin D deficiency in patients with diabetes and COVID- 19 infection.
32634717 2020. Application of Artificial Intelligence in COVID-19 drug repurposing.
32639233 2020. Concentration-dependent mortality of chloroquine in overdose.
32619390 2020. Shotgun proteomics analysis of SARS-CoV-2-infected cells and how it can optimize whole viral particle antigen production for vaccines.
32615862 2020. Profiles of COVID-19 clinical trials in the Chinese Clinical Trial Registry.
32616599 2020. Potential of regulatory T cell-based therapies in the management of severe COVID-19.
32640331 2020. Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pathways in health and disease.
32621202 2020. Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis.
32638628 2020. Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2.
32622993 2020. Prophylactic (hydroxy)chloroquine in COVID-19: potential relevance for cardiac arrhythmia risk.
32621881 2020. INCIDENCE OF ARRHYTHMIAS AND ELECTROCARDIOGRAPHIC ABNORMALITIES IN SYMPTOMATIC PEDIATRIC PATIENTS WITH PCR POSITIVE SARS-CoV-2 INFECTION INCLUDING DRUG INDUCED CHANGES IN THE CORRECTED QT INTERVAL (QTc).
32641876 2020. Curcumin: a Wonder Drug as a Preventive Measure for COVID19 Management.
32641874 2020. Hydroxychloroquine and Covid-19: A Cellular and Molecular Biology Based Update.
32643111 2020. Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease.
32640381 2020. Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches.
32642806 2020. Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab.
32645633 2020. An update on antiviral antibody-based biopharmaceuticals.
32645632 2020. Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.
32634603 2020. COVID-19 Treatment: Close to a Cure? - A Rapid Review of Pharmacotherapies for the Novel Coronavirus.
32646770 2020. Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab.
32639711 2020. CNS Penetration Ability: A Critical Factor for Drugs in the Treatment of SARS-CoV-2 Brain Infection.
32619190 2020. Passive immunization: Paradoxical and traditional method for new pandemic challenge COVID-19.
32648245 2020. COVID-19 and Mesenchymal Stem Cell Treatment; Mystery or Not.
32628223 2020. Very Long-acting Antivirals as Chemovaccines for Preventing Viral Infections.
32640172 2020. Poly(ADP-ribose) Polymerase Inhibition in Acute Lung Injury: A Re-emerging Concept.
32634026 2020. COVID-19 Clinical Trials: Unravelling a Methodological Gordian Knot.
32628535 2020. Regulatory T Cells for Treating Patients With COVID-19 and Acute Respiratory Distress Syndrome: Two Case Reports.
32647027 2020. Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study.
32632035 2020. Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARD.
32632034 2020. COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study.
32632030 2020. Response to: 'COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study' by Cuceoglu et al.
32620597 2020. Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study.
32641296 2020. Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations.
32631826 2020. Clinical trials of repurposed antivirals for SARS-CoV-2.
32639103 2020. Trainee Led Collaboratives, Clinical Trials And New Opportunities In The Covid-19 Era.
32644876 2020. Nutrients in prevention, treatment, and management of viral infections; special focus on Coronavirus.
32646867 2020. Vaccines, convalescent plasma, and monoclonal antibodies for covid-19.
32631851 2020. Urgent call for greater multilateralism and coordination of covid-19 trials.
32631850 2020. Covid-19: research methods must be flexible in a crisis.
32620554 2020. Dexamethasone in the management of covid -19.
32611587 2020. Covid-19: Lopinavir-ritonavir does not benefit hospitalised patients, UK trial finds.
32641344 2020. COVID-19 clinical trials: see it big and keep it simple.
32639062 2020. Serious adverse events with tocilizumab: pharmacovigilance as an aid to prioritize monitoring in COVID-19.
32627226 2020. Potential role of IL-17 blocking agents in the treatment of severe COVID-19?
32645204 2020. Double-bright (CD56bright/CD16bright) NK cell adoptive immunotherapy for SARS-CoV-2.
32621754 2020. COVID-19 pandemic and management of GIMEMA clinical trials: changes and challenges.
32639031 2020. Proteinase-activated receptor 1 (PAR1): A target for repurposing in the treatment of COVID-19?
32640179 2020. Current Therapies Under Investigation for COVID-19.
32633733 2020. Interaction of hydroxychloroquine with SARS-CoV2 functional proteins using all-atoms non-equilibrium alchemical simulations.
32613971 2020. Construction and immunogenic studies of a mFc fusion receptor binding domain (RBD) of spike protein as a subunit vaccine against SARS-CoV-2 infection.
32621392 2020. Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalised with COVID-19 are associated with greater disease severity.
32640049 2020. Immune checkpoint inhibition in the era of COVID-19.
32640019 2020. Proposing minimum requirements for announcing clinical trial results during the COVID-19 pandemic.
32628748 2020. Evaluating use cases for human challenge trials in accelerating SARS-CoV-2 vaccine development.
32648959 2020. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
32634894 2020. Smoking in critically ill patients with COVID-19: the Australian experience.
32628049 2020. Analytical Methods on Determination in Pharmaceuticals and Biological Materials of Chloroquine as Available for the Treatment of COVID-19.
32619167 2020. Effect of the Phytochemical Agents Against the SARS-CoV and Selected Some of them for Application to COVID-19: A Mini-Review.
32634080 2020. Repurposing Drugs for the Management of Patients with Confirmed Coronavirus Disease 2019 (COVID-19).
32634079 2020. The role of Chloroquine and Hydroxychloroquine in Immune Regulation and Diseases.
32628591 2020. Elucidating the Pivotal Role of Immune Players in the Management of COVID-19: Focus on Mesenchymal Stem Cells and Inflammation.
32648845 2020. Therapeutic targets and computational approaches on drug development for COVID-19.
32621718 2020. Shape-based Machine Learning Models for the potential Novel COVID-19 protease inhibitors assisted by Molecular Dynamics Simulation.
32643448 2020. Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19.
32632960 2020. Revisiting potential druggable targets against SARS-CoV-2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review.
32629169 2020. Repositioning chloroquine as antiviral prophylaxis against COVID-19: potential and challenges.
32616659 2020. BET 2: Hydroxychloroquine in the treatment of COVID-19.
32616658 2020. BET 1: Lopinavir-ritonavir and COVID-19.
32641191 2020. Bacillus Calmette-Guerin vaccination and clinical characteristics and outcomes of COVID-19 in Rhode Island, United States: a cohort study.
32648935 2020. SGLT2 inhibition and COVID-19: The road not taken.
32620680 2020. Do psychotropic drugs used during COVID-19 therapy have an effect on the treatment process?
32631083 2020. Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine - from HIV-1 infection to COVID-19.
32643980 2020. Predictor of poor prognosis of COVID-19 patients----liver injury.
32649840 2020. Liver injury in severe COVID-19 infection: current insights and challenges.
32639083 2020. Balancing infection control and frailty prevention during and after the COVID-19 pandemic: Introduction of the NCGG Home Exercise Program for Older People 2020.
32645727 2020. Isopathic Remedy Prepared from Convalescent Plasma as a Therapeutic Option for COVID-19?
32643512 2020. Thinking more about therapy with convalescent plasma for COVID-19 patients.
32633162 2020. Successful Treatment of Covid-19 Associated Cytokine Release Syndrome with Colchicine. A Case Report and Review of Literature.
32643997 2020. Effect of recombinant human granulocyte colony-stimulating factor on lymphocyte subsets in patients with COVID-19.
32615877 2020. Suggestions for Combatting COVID-19 by Natural Means in the Absence of Standard Medical Regimens.
32649272 2020. Combating COVID-19 and Building Immune Resilience: A Potential Role for Magnesium Nutrition?
32643552 2020. Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor.
32643550 2020. Potential of NO donor furoxan as SARS-CoV-2 main protease (M(pro)) inhibitors: in silico analysis.
32643529 2020. Natural-like products as potential SARS-CoV-2 M(pro) inhibitors: in-silico drug discovery.
32627715 2020. Screening of phytochemical compounds of Tinospora cordifolia for their inhibitory activity on SARS-CoV-2: an in silico study.
32627689 2020. Possibility of HIV-1 protease inhibitors-clinical trial drugs as repurposed drugs for SARS-CoV-2 main protease: a molecular docking, molecular dynamics and binding free energy simulation study.
32619162 2020. Bacterial protein azurin and derived peptides as potential anti-SARS-CoV-2 agents: insights from molecular docking and molecular dynamics simulations.
32619134 2020. Epitope based peptide vaccine against SARS-COV2: an immune-informatics approach.
32618198 2020. Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights.
32643158 2020. Excavating SARS-coronavirus 2 genome for epitope-based subunit vaccine synthesis using immunoinformatics approach.
32643200 2020. Convalescent plasma therapy in patients with COVID-19.
32647045 2020. Hydroxychloroquine and COVID-19: critiquing the impact of disease public profile on policy and clinical decision-making.
32644254 2020. Early use of tocilizumab in the prevention of adult respiratory failure in SARS-CoV-2 infections and the utilization of interleukin-6 levels in the management.
32644224 2020. Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection.
32644208 2020. Erythropoietin Induced Hemoglobin Sub-Unit Beta may Stimulate Innate Immune RNA Virus Pattern Recognition, Suppress Reactive Oxygen Species, Reduce ACE2 Viral Doorway Opening and Neutrophil Extracellular Traps against Covid-19.
32633865 2020. A retrospective review of memantine use and COVID-19-associated mortality from a national database.
32633831 2020. RNA-dependent RNA Polymerase of SARS-CoV-2 as a Therapeutic Target.
32621621 2020. Lopinavir/ritonavir is associated with pneumonia resolution in COVID-19 patients with influenza coinfection: a retrospective matched-pair cohort study.
32617989 2020. Efficacy and safety of umifenovir for coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.

32634602 2020. Corticosteroid therapy for patients with CoVID-19 pneumonia: a before-after study.
32629115 2020. A pharmacological perspective of Chloroquine in SARS-CoV-2 infection.
32619764 2020. Case reports study of the first five patients COVID-19 treated with remdesivir in France.
32634589 2020. Potential effective treatment for COVID-19: systematic review and meta-analysis of the severe infectious disease with convalescent plasma therapy.
32623082 2020. Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19.
32623080 2020. An Observational Cohort Study of Hydroxychloroquine and Azithromycin for COVID-19: (Can't Get No) Satisfaction.
32629817 2020. Influence of Herbal Medicines on HMGB1 Release, SARS-CoV-2 Viral Attachment, Acute Respiratory Failure, and Sepsis. A Literature Review.
32617855 2020. Phylogenetic Analysis and Structural Perspectives of RNA-Dependent RNA-Polymerase Inhibition from SARs-CoV-2 with Natural Products.
32627127 2020. Clinical guidance for navigating the QTc-prolonging and arrhythmogenic potential of pharmacotherapy during the COVID-19 pandemic.
32623068 2020. Nucleic Acid Approaches to Antibody-based Therapeutics for COVID-19: A Perspective.
32634126 2020. SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy.
32629768 2020. Role of Lopinavir/Ritonavir in the Treatment of Covid-19: A Review of Current Evidence, Guideline Recommendations, and Perspectives.
32630746 2020. SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches-Insights into Chemical Structure-Biological Activity and Toxicological Screening.
32622963 2020. Mesenchymal stromal cells and their secreted extracellular vesicles as therapeutic tools for COVID-19 pneumonia? ().
32622008 2020. Azithromycin and SARS-CoV-2 infection: where we are now and where we are going.
32636240 2020. BCG vaccine and COVID-19: implications for infection prophylaxis and cancer immunotherapy.
32611687 2020. On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19.
32627442 2020. Convalescent Plasma Therapy in Coronavirus Disease 2019: a Case Report and Suggestions to Overcome Obstacles.
32638109 2020. Mild COVID-19 infection in an NMO patient treated with tocilizumab: a confirmation of anti-IL-6 protective role?
32646487 2020. Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL(pro) targeting repurposed drug candidates.
32635935 2020. Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach.
32631442 2020. Systematic review of the registered clinical trials for coronavirus disease 2019 (COVID-19).
32650019 2020. Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19.
32629788 2020. Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy.
32610445 2020. Microbial Natural Products as Potential Inhibitors of SARS-CoV-2 Main Protease (M(pro)).
32634550 2020. Aptamers, the bivalent agents as probes and therapies for coronavirus infections: A systematic review.
32641037 2020. Caspase1/11 signaling affects muscle regeneration and recovery following ischemia, and can be modulated by chloroquine.
32647131 2020. Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice.
32648153 2020. The risk of QTc-interval prolongation in COVID-19 patients treated with chloroquine.
32641560 2020. COVID-19 and vitamin D deficiency, a fatal combination?
32645974 2020. SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings.
32619723 2020. Edaravone: A potential treatment for the COVID-19-induced inflammatory syndrome?
32622723 2020. Chinese herbal medicine for coronavirus disease 2019: A systematic review and meta-analysis.
32629137 2020. Ultraviolet-based Biophotonic Technologies and COVID-19.
32641511 2020. Discovery of potent thrombin inhibitors from a protease-focused DNA-encoded chemical library.
32621829 2020. Letter to the editor regarding "Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable".
32638884 2020. Primum non nocere - Are chloroquine and hydroxychloroquine safe prophylactic/treatment options for SARS-CoV-2 (covid-19)?
32616763 2020. A candidate multi-epitope vaccine against SARS-CoV-2.
32638647 2020. Alternative management of Covid-19 infection.
32636116 2020. First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemia.
32645478 2020. Hydroxychloroquine safety: A meta-analysis of randomized controlled trials.
32629139 2020. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".
32635353 2020. Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation During Acute Respiratory Distress: A Case Report and Literature Review.
32640619 2020. Prospects and Challenges in the Development of Universal Influenza Vaccines.
32635180 2020. Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design.
32621841 2020. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.
32629804 2020. Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review.
32620700 2020. Low Dose Radiation to COVID-19 Patients to Ease the Disease Course and Reduce the Need of Intensive Care.
32623965 2020. Are we aware of potential interactions between drugs used in lung cancer and drugs used in the treatment of COVID-19?
32628262 2020. The Development of COVID-19 Vaccines: Safeguards Needed.
32628244 2020. Developing a SARS-CoV-2 Vaccine at Warp Speed.
32614442 2020. Evolution of Altered Sense of Smell or Taste in Patients With Mildly Symptomatic COVID-19.
32613691 2020. Editorial - Nutritional Status Affects COVID-19 Patient Outcomes.
32613660 2020. Evaluation of Nutritional Risk and its Association With Mortality Risk in Severe and Critically Ill COVID-19 Patients.
32619276 2020. Low dose radiation as a treatment for COVID-19 pneumonia: a threat or real opportunity?
32619669 2020. Virtual screening based on molecular docking of possible inhibitors of Covid-19 main protease.
32633860 2020. Safety of Plasma Infusions in Parkinson's Disease.
32649078 2020. Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.
32649077 2020. Remdesivir for the Treatment of Covid-19 - Preliminary Report.
32649076 2020. Remdesivir for the Treatment of Covid-19 - Preliminary Report.
32649075 2020. Remdesivir for the Treatment of Covid-19 - Preliminary Report.
32649074 2020. Remdesivir for the Treatment of Covid-19 - Preliminary Report.
32643410 2020. Bioactive compounds from marine resources against novel corona virus (2019-nCoV): in silico study for corona viral drug.
32636505 2020. COVID-19 platform trial delivers.
32623442 2020. Going back in time for an antibody to fight COVID-19.
32645305 2020. Golden Anniversary of the Nicotinic Receptor.
32618794 2020. Tocilizumab and Remdesivir in a Pregnant Patient With Coronavirus Disease 2019 (COVID-19).
32615642 2020. Is povidone-iodine mouthwash effective against SARS-CoV-2? First in vivo tests.
32613637 2020. Naringenin, a flavanone with antiviral and anti-inflammatory effects: A promising treatment strategy against COVID-19.
32648294 2020. COVID-19: Phylogenetic approaches may help in finding resources for natural cure.
32647056 2020. BCG vaccine protection from severe coronavirus disease 2019 (COVID-19).
32648313 2020. Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection.
32614102 2020. Using heat to kill SARS-CoV-2.
32646977 2020. Can interferons stop COVID-19 before it takes hold?
32649367 2020. Potential Immunotherapeutic Targets For Hypoxia Due to COVI-FLU.
32619318 2020. COVID-19 drug repurposing: Summary statistics on current clinical trials and promising untested candidates.
32627216 2020. Characteristics and serological patterns of COVID-19 convalescent plasma donors: optimal donors and timing of donation.
32639598 2020. SARS-CoV2 and immunosuppression: a double-edged sword.
32629531 2020. Severe COVID-19 in a patient with chronic graft-versus-host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib.
32614684 2020. Review of the SARS-CoV-2 in Wuhan and Analysis as Well as Prediction of Therapeutic Drugs.

32388537 2020. Designing of improved drugs for COVID-19: Crystal structure of SARS-CoV-2 main protease M(pro).
32532959 2020. The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin.
32423553 2020. Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection.
32531235 2020. Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein.
32430279 2020. Gut microbiota and Covid-19- possible link and implications.
32416259 2020. On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2.
32558150 2020. Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation.
32585135 2020. Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike.
32546195 2020. Micronutrient status of COVID-19 patients: a critical consideration.
32559343 2020. Rationale for targeting Complement in COVID-19.
32543705 2020. Evolutionary relationships and sequence-structure determinants in human SARS coronavirus-2 spike proteins for host receptor recognition.
32592394 2020. A role for selenium-dependent GPX1 in SARS-CoV-2 virulence.
32590326 2020. Pulmonary surfactant itself must be a strong defender against SARS-CoV-2.
32562814 2020. Statins and other drugs: Facing COVID-19 as a vascular disease.
32424591 2020. COVID-19, acute respiratory distress syndrome (ARDS), and hyperbaric oxygen therapy (HBOT): what is the link?
32598884 2020. Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge.
32481719 2020. The Role of MicroRNA in the Airway Surface Liquid Homeostasis.
32534506 2020. Bradykinin as a Probable Aspect in SARS-Cov-2 Scenarios: Is Bradykinin Sneaking out of Our Sight?
32600316 2020. The cholinergic anti-inflammatory pathway alleviates acute lung injury.
32537478 2020. Airways Expression of SARS-CoV-2 Receptor, ACE2, and TMPRSS2 Is Lower in Children Than Adults and Increases with Smoking and COPD.
32595361 2020. Gut-lung axis and dysbiosis in COVID-19.
32591496 2020. Door to the cell for COVID-19 opened, leading way to therapies.
32602262 2020. Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID-19: A Case Series.
32555145 2020. Targeting the entry step of SARS-CoV-2: a promising therapeutic approach.
32594085 2020. Early Hemoperfusion for Cytokine Removal May Contribute to Prevention of Intubation in Patients Infected with COVID-19.
32582574 2020. ACE2, Much More Than Just a Receptor for SARS-COV-2.
32545271 2020. Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract.

32573788 2020. Elucidation of Cellular Targets and Exploitation of the Receptor Binding Domain of SARS-CoV-2 for vaccine and monoclonal antibody synthesis.
32551652 2020. Critical Differences Between the Binding Features of the Spike Proteins of SARS-CoV-2 and SARS-CoV.
32551648 2020. The Discovery of a Putative Allosteric Site in the SARS-CoV-2 Spike Protein Using an Integrated Structural/Dynamic Approach.
32571797 2020. Identification of common deletions in the spike protein of SARS-CoV-2.
32606248 2020. Genomic discovery of an evolutionarily programmed modality for small-molecule targeting of an intractable protein surface.
32602627 2020. Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection.

32417594 2020. Supplements for COVID-19: A modifiable environmental risk.

32665809 2020. Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment.
32665808 2020. Exploiting Existing Molecular Scaffolds for Long-Term COVID Treatment.
32667191 2020. Hard Nanomaterials in Time of Viral Pandemics.
32717094 2020. Cannabis terapeutico y COVID-19: entre el oportunismo y la infoxicacion.
32711735 2020. Reverse genetic systems: Rational design of coronavirus live attenuated vaccines with immune sequelae.
32705585 2020. Associations between hypovitaminosis D and COVID-19: a narrative review.
32653224 2020. BCG as a game-changer to prevent the infection and severity of COVID-19 pandemic?
32687406 2020. Inhibiting Fusion with Cellular Membrane System: Therapeutic Options to Prevent Severe Acute Respiratory Syndrome Coronavirus-2 Infection.
32653550 2020. Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?
32673060 2020. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial.
32673059 2020. The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale.
32667853 2020. Update Alert: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19.
32653425 2020. Does androgen deprivation therapy protect against severe complications from COVID-19?
32692238 2020. Tongue diagnosis and treatment in traditional Chinese medicine for severe COVID-19: a case report.
32660993 2020. Safety, pharmacokinetics, and activity of high-dose ivermectin and chloroquine against the liver-stage of Plasmodium cynomolgi infection in Rhesus Macaques.
32708578 2020. The Role of Glutathione in Protecting against the Severe Inflammatory Response Triggered by COVID-19.
32679055 2020. In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2.
32659293 2020. Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection.
32659292 2020. Immunoglobulin fragment F(ab')2 against RBD potently neutralizes SARS-CoV-2 in vitro.
32660794 2020. Response to: Amantadine Treatment for People with COVID-19.
32682671 2020. Nutrition management for critically and acutely unwell hospitalised patients with coronavirus disease 2019 (COVID-19) in Australia and New Zealand.
32710969 2020. Approaching Coronavirus Disease 2019: mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2.
32688139 2020. PARP-inhibitors in a non-oncological indication as COVID-19: Are we aware about its potential role as anti-thrombotic drugs? The discussion is open.
32679775 2020. Deamidated Human Triosephosphate Isomerase is a Promising Druggable Target.
32665234 2020. Drug treatments affecting ACE2 in COVID-19 infection: a systematic review protocol.
32717399 2020. Purinergic signaling in infectious diseases of the central nervous system.
32679175 2020. Regional differences in use of immune-modulating catechins should be investigated regarding COVID-19.
32679174 2020. Reply to the Letter to the Editor: Regional differences in dietary use of immune-modulating catechins should be investigated regarding COVID-19.
32615072 2020. Ivermectin: potential candidate for the treatment of Covid 19.
32717278 2020. The Multiple Effects of SGLT2 Inhibitors Suggest Potential Benefit in COVID-19 Patients.
32643141 2020. Ion channel inhibition against COVID-19: A novel target for clinical investigation.
32645327 2020. A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS.
32714563 2020. Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro.
32707096 2020. Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients.
32668216 2020. Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice.
32711111 2020. Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19.
32710890 2020. The minimal effect of zinc on the survival of hospitalized patients with Covid-19: an observational study.
32676976 2020. Exploring an Integrative Therapy for Treating COVID-19: A Randomized Controlled Trial.
32632717 2020. In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking.
32665783 2020. Current strategies against COVID-19.
32667534 2020. Pandemia de COVID19: implicacoes para (in)seguranca alimentar e nutricional.
32661912 2020. Tocilizumab, Adipokines and Severe Complications of COVID-19.
32661911 2020. Authors' Reply to: Tocilizumab, Adipokines and Severe Complications of COVID-19.
32707089 2020. Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous n-acetylcysteine.
32673711 2020. mTORC inhibitor Sirolimus deprograms monocytes in "cytokine storm" in SARS-CoV2 secondary hemophagocytic lymphohistiocytosis- like syndrome.
32663514 2020. Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?: In reply to, 'COVID-19: Immunology and treatment options', Felsenstein, Herbert McNamara et al. 2020'.
32675166 2020. COVID-19, hydroxychloroquine and the eighth alternative.
32717568 2020. FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy.
32705604 2020. Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ?
32709544 2020. COVID-19 and hydroxychloroquine: Let the available data speak for themselves.
32668460 2020. COVID-19 Therapeutics: Making Sense of It All.
32662982 2020. Calcium Channel Blockers: A Possible Potential Therapeutic Strategy for the Treatment of Alzheimer's Dementia Patients with SARS-CoV-2 Infection.
32687696 2020. Old drugs for a new virus: repurposed approaches for combating COVID-19.
32686128 2020. Montelukast in children with allergic rhinitis amid COVID-19 pandemic.
32696443 2020. The Role of Hyperbaric Oxygen Treatment for COVID-19: A Review.
32716768 2020. The Regulation of COVID-19 "Challenge" Studies.
32709838 2020. Unusual Early Recovery of a Critical COVID-19 Patient After Administration of Intravenous Vitamin C.
32661220 2020. First-in-Man: Case Report of Selective C-Reactive Protein Apheresis in a Patient with SARS-CoV-2 Infection.
32694294 2020. Nutrition Support in the ICU-A Refresher in the Era of COVID-19.
32668178 2020. Inhaled Corticosteroids and COVID-19.
32668164 2020. Reply to: Inhaled Corticosteroids and COVID-19.
32711585 2020. More Studies are Needed on the Link between Metformin and Decreased Mortality in Diabetic COVID-19 Patients.
32705976 2020. Artemisia Spp. Derivatives for COVID-19 Treatment: Anecdotal Use, Political Hype, Treatment Potential, Challenges, and Road Map to Randomized Clinical Trials.
32663348 2020. Current status of COVID-19 (pre)clinical vaccine development.
32692580 2020. Repurposing Existing Drugs for the Treatment of COVID-19.
32687756 2020. Remdesivir improved time to recovery in adults hospitalized with COVID-19 and lower respiratory tract involvement.
32661006 2020. Efficacy and safety of interferon beta-1a in treatment of severe COVID-19: A randomized clinical trial.
32686943 2020. Potential role of Bacillus Calmette-Guerin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
32713288 2020. Chloroquine in fighting COVID-19: good, bad, or both?
32692801 2020. COVID-19 Docking Server: A meta server for docking small molecules, peptides and antibodies against potential targets of COVID-19.
32663708 2020. Reckoning a fungal metabolite, Pyranonigrin A as a potential Main protease (M(pro)) inhibitor of novel SARS-CoV-2 virus identified using docking and molecular dynamics simulation.
32699011 2020. Intensive immunosuppression reduces deaths in covid-19-associated cytokine storm syndrome, study finds.
32698999 2020. Are we responsible for the racial inequalities of covid-19?
32665225 2020. Covid-19: Experts criticise claim that remdesivir cuts death rates.
32693436 2020. Model-Informed Drug Repurposing: Viral Kinetic Modeling to Prioritize Rational Drug Combinations for COVID-19.
32692462 2020. ABNORMAL LABORATORY FINDINGS AND PLASMA CONCENTRATION MONITORING OF LOPINAVIR AND RITONAVIR IN COVID-19.
32687645 2020. Clinical outcomes and adverse events in patients hospitalised with COVID -19, treated with off- label hydroxychloroquine and azithromycin.
32656822 2020. Insights from compassionate use of tocilizumab for COVID-19 to inform appropriate design of randomised controlled trials.
32652563 2020. Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infection.
32713358 2020. COVID-19 and Misinformation: How an Infodemic Fueled the prominence of Vitamin D.
32703328 2020. THE RATIONALE FOR A MULTI-STEP THERAPEUTIC APPROACH BASED ON ANTIVIRALS, DRUGS, AND NUTRIENTS WITH IMMUNOMODULATORY ACTIVITY IN PATIENTS WITH CORONAVIRUS-SARS2-INDUCED DISEASE OF DIFFERENT SEVERITY.
32700336 2020. Non-steroidal anti-inflammatory drugs, prostaglandins and COVID-19.
32681537 2020. Safety perspectives on presently considered drugs for the treatment of COVID-19.
32671829 2020. Targeting zinc metalloenzymes in COVID-19.
32713374 2020. Clozapine treatment and risk of COVID-19.
32662814 2020. Integrative pharmacological mechanism of vitamin C combined with glycyrrhizic acid against COVID-19: findings of bioinformatics analyses.
32717117 2020. Peptidyl Acyloxymethyl Ketones as Activity-Based Probes for the Main Protease of SARS-CoV-2.
32700795 2020. Targeting SARS-CoV-2 RBD interface: a supervised computational data-driven approach to identify potential modulators.
32702997 2020. IL-6 Blockade and QTc Prolongation in COVID-19.
32671847 2020. In response to: Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalised with COVID-19 are associated with greater disease severity.
32710937 2020. Micronutrients as immunomodulatory tools for COVID-19 management.
32706859 2020. Remdesivir for Severe COVID-19 versus a Cohort Receiving Standard of Care.
32674126 2020. Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial.
32671407 2020. Long-term outcome of short-course high-dose glucocorticoids for SARS: a 17-year follow-up in SARS survivors.
32667978 2020. Treatment of COVID-19 - Evidence-Based or Personalized Medicine?
32651997 2020. Tocilizumab for treatment of mechanically ventilated patients with COVID-19.
32687630 2020. Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID-19 Infection.
32674594 2020. Endpoints for randomized controlled clinical trials for COVID-19 treatments.
32666816 2020. Highly efficient clinical trial designs for reliable screening of under-performing treatments: Application to the COVID-19 Pandemic.
32650672 2020. Clinical trials in the time of a pandemic.
32650671 2020. Editorial: Clinical trial design in the era of COVID-19.
32651961 2020. Updates on the Pharmacology of Chloroquine against Coronavirus Disease 2019 (COVID-19): A Perspective on its Use in the General and Geriatric Population.
32675717 2020. Role for antimalarials in the management of COVID-19.
32674732 2020. Ligand- and structure-based virtual screening of Lamiaceae diterpenes with potential activity against a novel coronavirus (2019-nCoV).
32686260 2020. Insights in chloroquine action: perspectives and implications in Malaria and COVID-19.
32692700 2020. Plasma-derived therapy: can the survivors of COVID-19 help the defenseless?
32690491 2020. Dexamethasone for COVID-19: preliminary findings.
32705683 2020. High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection.
32688337 2020. Growth hormone therapy at the time of Covid-19 pandemic: adherence and drug supply issues.
32706089 2020. Potential usefulness of pentoxifylline, a non-specific phosphodiesterase inhibitor with anti-inflammatory, anti-thrombotic, antioxidant, and anti-fibrogenic properties, in the treatment of SARS-CoV-2.
32706087 2020. A systematic review on the efficacy and safety of IL-6 modulatory drugs in the treatment of COVID-19 patients.
32700604 2020. Itolizumab, an anti-CD6 monoclonal antibody, as a potential treatment for COVID-19 complications.

32658735 2020. Identification of potential inhibitors of three key enzymes of SARS-CoV2 using computational approach.
32698853 2020. Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence.
32693829 2020. Chinese herbal experience for the 2019 novel coronavirus.
32690059 2020. Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials.
32684169 2020. Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study.
32682440 2020. Blocking IL-1 to prevent respiratory failure in COVID-19.
32680535 2020. Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure-a cautionary case series.
32664996 2020. Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation.
32653043 2020. Administration of umbilical cord mesenchymal stem cells in patients with severe COVID-19 pneumonia.
32653015 2020. Comparison of hydroxychloroquine, lopinavir/ritonavir, and standard of care in critically ill patients with SARS-CoV-2 pneumonia: an opportunistic retrospective analysis.
32656044 2020. Pulse Therapy With Corticosteroids and Intravenous Immunoglobulin in the Management of Severe Tocilizumab-Resistant COVID-19: A Report of Three Clinical Cases.
32661859 2020. Can Vitamins, as Epigenetic Modifiers, Enhance Immunity in COVID-19 Patients with Non-communicable Disease?
32665127 2020. Are we fully exploiting type I Interferons in today's fight against COVID-19 pandemic?
32683320 2020. Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19).
32696429 2020. Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines.
32696108 2020. Pharmaco-Immunomodulatory Therapy in COVID-19.
32655654 2020. Coronavirus disease 2019 (COVID-19): latest developments in potential treatments.
32691021 2020. Tocilizumab improves survival in patients with persistent hypoxia in severe COVID-19 pneumonia.
32662949 2020. Modulation of the acute defence reaction by eplerenone prevents cardiac disease progression in viral myocarditis.
32696234 2020. Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies.
32653152 2020. Waste in COVID-19 clinical trials conducted in western Europe.
32651040 2020. Linking hydroxychloroquine to hemolysis in a 'suspected' glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection - a critical appraisal.
32693294 2020. Flavaglines as natural products targeting eIF4A and prohibitins: From traditional Chinese medicine to antiviral activity against coronaviruses.
32668312 2020. A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat and control COVID-19 infection.
32682787 2020. Advances in the possible treatment of COVID-19: A review.
32700671 2020. Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2.
32707160 2020. An overview of safety assessment of the medicines currently used in the treatment of COVID-19 disease.
32679367 2020. Selenium - associated gene signatures within the SARS-CoV-2 - host genomic interaction interface.
32653511 2020. Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19.
32714335 2020. Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine.
32695123 2020. GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response.
32670297 2020. Severe COVID-19: NLRP3 Inflammasome Dysregulated.
32705405 2020. Traditional Chinese medicine for combating COVID-19.
32651936 2020. The role played by traditional Chinese medicine in preventing and treating COVID-19 in China.
32714938 2020. Physical Exercise Potentials Against Viral Diseases Like COVID-19 in the Elderly.
32671084 2020. Randomized Controlled Study Evaluating Efficiency of Low Intensity Transcranial Direct Current Stimulation (tDCS) for Dyspnea Relief in Mechanically Ventilated COVID-19 Patients in ICU: The tDCS-DYSP-COVID Protocol.
32714193 2020. Turning the Tide: Natural Products and Natural-Product-Inspired Chemicals as Potential Counters to SARS-CoV-2 Infection.
32698626 2020. Anti-COVID drugs: repurposing existing drugs or search for new complex entities, strategies and perspectives.
32672061 2020. Evidence supporting the use of peptides and peptidomimetics as potential SARS-CoV-2 (COVID-19) therapeutics.
32662664 2020. N-acetylcysteine as a potential treatment for novel coronavirus disease 2019.
32682763 2020. Association between famotidine use and COVID-19 severity in Hong Kong: a territory-wide study.
32717321 2020. Genomics approaches to synthesis plant-based biomolecules for therapeutic applications to combat SARS-CoV-2.
32703797 2020. Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter trial.
32703791 2020. Complement C5 inhibition in patients with COVID-19 - a promising target?
32676695 2020. Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection.
32712334 2020. Ribavirin Therapy For Severe COVID-19: A Retrospective Cohort Study.
32712333 2020. Tocilizumab for severe COVID-19: a systematic review and meta-analysis.
32708322 2020. Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?
32717282 2020. The Lord of the NanoRings: cyclodextrins and the battle against SARS-CoV-2.
32711037 2020. Radiation Therapy as a Treatment for COVID-19?
32707264 2020. Low-dose Whole-lung Irradiation for COVID-19 Pneumonia: Short Course Results.
32713677 2020. Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients.
32707230 2020. Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: implications for treatment with IFN-beta and IFN inducer.
32662677 2020. The combination of artificial intelligence and systems biology for intelligent vaccine design.
32693646 2020. A real-world disproportionality analysis of FDA Adverse Event Reporting System (FAERS) events for baricitinib.
32693650 2020. Tocilizumab for patients with severe COVID-19: a retrospective, multi-centre study.
32693652 2020. Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection.
32662690 2020. The Use of IV vitamin C for patients with COVID-19: a single center observational study.
32700398 2020. Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study.
32657483 2020. Pharmacological agents under investigation in the treatment of coronavirus disease 2019 and the importance of melatonin.
32691927 2020. Drug interactions with potential antivirals used for COVID-19 in older persons.
32701395 2020. Designing Pull Funding For A COVID-19 Vaccine.
32706599 2020. A Social and Behavioral Research Agenda to Facilitate COVID-19 Vaccine Uptake in the United States.
32703069 2020. Promise and challenges in the development of COVID-19 vaccines.
32703064 2020. COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines.
32693665 2020. COVID-19 - Important considerations for developing and using a vaccine.
32663051 2020. An immunotherapeutic method for COVID-19 patients: a soluble ACE2-Anti-CD16 VHH to block SARS-CoV-2 Spike protein.
32710535 2020. MMR Vaccine and Covid-19: A Myth or a Low Risk-High Reward Preventive Measure?
32713336 2020. Chloroquine as chemoprophylaxis for COVID-19: Will this work?
32673140 2020. Re: Low-dose radiation therapy for COVID-19 pneumonia: is there any supportive evidence?
32674673 2020. COVID-19 and Vitamin D deficiency; the two pandemics. Are they correlated?
32666683 2020. COVID-19 and chronic obstructive pulmonary disease: therapeutic potential of blocking SARS-CoV2 adhesion factors.
32673081 2020. Chinese Herbal Medicines During the Covid-19 Pandemic: A Role for Observational Studies.
32659175 2020. Can Vitamin D and L-Cysteine Co-Supplementation Reduce 25(OH)-Vitamin D Deficiency and the Mortality Associated with COVID-19 in African Americans?
32688374 2020. Pharmacokinetics of lopinavir/ritonavir oral solution to treat COVID-19 in mechanically ventilated ICU patients.
32720578 2020. Identification of some novel oxazine substituted 9-anilinoacridines as SARS-CoV-2 inhibitors for COVID-19 by molecular docking, free energy calculation and molecular dynamics studies.
32720577 2020. Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2 via RNA-dependent RNA polymerase (RdRp) inhibition: an in-silico analysis.
32720571 2020. Investigating the binding affinity, interaction, and structure-activity-relationship of 76 prescription antiviral drugs targeting RdRp and Mpro of SARS-CoV-2.
32715956 2020. Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2.
32705962 2020. Molecular docking and dynamics study of natural compound for potential inhibition of main protease of SARS-CoV-2.
32705953 2020. Identification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis.
32705952 2020. In-Silico approach for identification of effective and stable inhibitors for COVID-19 main protease (M(pro)) from flavonoid based phytochemical constituents of Calendula officinalis.
32705942 2020. Computational drug repurposing for the identification of SARS-CoV-2 main protease inhibitors.
32698693 2020. Dual inhibitors of SARS-CoV-2 proteases: pharmacophore and molecular dynamics based drug repositioning and phytochemical leads.
32698689 2020. Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development.
32696720 2020. Antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19.
32696718 2020. Comparative molecular investigation of the potential inhibitors against SARS-CoV-2 main protease: a molecular docking study.
32692306 2020. Virtual screening, molecular dynamics and structure-activity relationship studies to identify potent approved drugs for Covid-19 treatment.
32691697 2020. Natural derivatives with dual binding potential against SARS-CoV-2 main protease and human ACE2 possess low oral bioavailability: a brief computational analysis.
32691680 2020. Cyanobacterial metabolites as promising drug leads against the M(pro) and PL(pro) of SARS-CoV-2: an in silico analysis.
32684114 2020. In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors.
32684109 2020. Targeting virus-host interaction by novel pyrimidine derivative: an in silico approach towards discovery of potential drug against COVID-19.
32679006 2020. Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CL(pro)).
32677591 2020. The latitude hypothesis, vitamin D, and SARS-Co-V2.
32677545 2020. Approach to the mechanism of action of hydroxychloroquine on SARS-CoV-2: a molecular docking study.
32677533 2020. Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach.
32672528 2020. Computer-aided screening for potential TMPRSS2 inhibitors: a combination of pharmacophore modeling, molecular docking and molecular dynamics simulation approaches.
32666910 2020. Computational investigation of potential inhibitors of novel coronavirus 2019 through structure-based virtual screening, molecular dynamics and density functional theory studies.
32662333 2020. Computational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease.
32657643 2020. Identification of potential drugs against SARS-CoV-2 non-structural protein 1 (nsp1).
32697000 2020. Corticosteroids-induced osteonecrosis in COVID-19: a call for caution.
32658005 2020. Anti-inflammatory therapies for pericardial diseases in the COVID-19 pandemic: safety and potentiality.
32700555 2020. Hydroxychloroquine in COVID-19 Therapy: Protection Versus Proarrhythmia.
32692858 2020. Stem cell therapies for COVID-19: Strategy and application.
32687345 2020. Structure-based virtual screening to discover potential lead molecules for the SARS-CoV-2 main protease.
32678588 2020. SARS-CoV-2 Main Protease: A Molecular Dynamics Study.
32694358 2020. Hydroxychloroquine and Chloroquine in COVID-19: A Survey of Prescription Patterns Among Rheumatologists.
32700580 2020. Pharmacotherapy in COVID-19 patients: A review of ACE2-raising drugs and their clinical safety.
32677610 2020. Antiviral and virucidal effects of curcumin on transmissible gastroenteritis virus in vitro.
32651218 2020. A Case for Targeting Th17 Cells and IL-17A in SARS-CoV-2 Infections.
32702095 2020. Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy.
32651586 2020. Do Not Minimize the Impact of Cellular Immunity in the Development of Vaccines and Therapeutics for COVID-19.

32666357 2020. Vitamin D and COVID-19.
32685369 2020. Early use of tocilizumab in respiratory failure associated with acute COVID -19 pneumonia in recipients with solid organ transplantation.
32677493 2020. Obesity, COVID-19 and immunotherapy: the complex relationship!
32664810 2020. Recovery of COVID-19 acute respiratory distress syndrome with tocilizumab: successful outcome in two critically ill patients.
32651941 2020. That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19.
32656668 2020. SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus.
32683296 2020. Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: A systematic review.
32687949 2020. Chloroquine and Hydroxychloroquine in Coronavirus Disease 2019 (COVID-19). Facts, Fiction & the Hype. A Critical Appraisal.
32674929 2020. Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?
32674928 2020. Review of: "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949.
32693122 2020. A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor.
32682041 2020. Design of a multi-epitope vaccine against SARS-CoV-2 using immunoinformatics approach.
32698494 2020. Self-Amplifying RNA Viruses as RNA Vaccines.
32674481 2020. Immunomodulatory Effects of Hydroxychloroquine and Chloroquine in Viral Infections and Their Potential Application in Retinal Gene Therapy.
32691002 2020. A consensus guideline of herbal medicine for coronavirus disease 2019.
32691000 2020. Herbal medicine for the management of COVID-19 during the medical observation period: A review of guidelines.
32652231 2020. Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma.
32652194 2020. Retrospective Analysis of Dermatological Adverse Events Associated with Hydroxychloroquine Reported to the United States Food and Drug Administration.
32674834 2020. Plasma Therapies and Parabiosis in the COVID-19 Era.
32690352 2020. Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study.
32694923 2020. Blood Targets of Adjuvant Drugs Against COVID19.
32713161 2020. The potential effects of DPP-4 inhibitors on cardiovascular system in COVID-19 patients.
32677763 2020. Lessons from SARS and MERS remind us of the possible therapeutic effects of implementing a siRNA strategy to target COVID-19: Shoot the messenger!
32672454 2020. Bioactivity Profile Similarities to Expand the Repertoire of COVID-19 Drugs.
32655741 2020. First Reported Use of Highly Adsorptive Hemofilter in Critically Ill COVID-19 Patients in the USA.
32683212 2020. Update I. A systematic review on the efficacy and safety of chloroquine/hydroxychloroquine for COVID-19.
32680687 2020. Therapeutic plasma exchange in life-threatening COVID-19 and associated cytokine release syndrome.
32682930 2020. Could Bordetella pertussis vaccine protect against coronavirus COVID-19?
32695833 2020. Protective Immunity against SARS Subunit Vaccine Candidates Based on Spike Protein: Lessons for Coronavirus Vaccine Development.
32652164 2020. Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis.
32666875 2020. Therapeutic Plasma Exchange: A potential Management Strategy for Critically Ill COVID-19 Patients.
32654098 2020. QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin.
32661074 2020. Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines.
32702590 2020. Intermolecular interaction among Remdesivir, RNA and RNA-dependent RNA polymerase of SARS-CoV-2 analyzed by fragment molecular orbital calculation.
32682142 2020. Neuromyelitis optica practice and prescribing changes in the setting of Covid19: A survey of neurologists.
32684166 2020. Withaferin A: a potential therapeutic agent against COVID-19 infection.
32685234 2020. Prophetic Medicine-Nigella Sativa (Black cumin seeds) - Potential herb for COVID-19?
32658489 2020. Michael Acceptors Tuned by the Pivotal Aromaticity of Histidine to Block COVID-19 Activity.
32653646 2020. SARS-CoV and SARS-CoV-2 main protease residue interaction networks change when bound to inhibitor N3.
32718719 2020. Interacciones medicamentosas potenciales en pacientes COVID 19 en tratamiento con lopinavir/ritonavir.
32718715 2020. Reacciones adversas a farmacos utilizados en el tratamiento especifico de la infeccion por SARS-CoV-2.
32712223 2020. Commentary. Eliminating Vitamin D Deficiency During the COVID-19 Pandemic: A Call to Action.
32712272 2020. Blood nitrate and nitrite modulating nitric oxide bioavailability: potential therapeutic functions in COVID-19.
32708526 2020. Selenium Deficiency Is Associated with Mortality Risk from COVID-19.
32709055 2020. Polymorphism and Selection Pressure of SARS-CoV-2 Vaccine and Diagnostic Antigens: Implications for Immune Evasion and Serologic Diagnostic Performance.
32707768 2020. Two Examples of RNA Aptamers with Antiviral Activity. Are Aptamers the Wished Antiviral Drugs?
32713784 2020. Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review.
32703528 2020. Replica: Ivermectina en COVID-19. inverted question markArgumentum ad ignorantiam?
32719454 2020. Identification of key interactions between SARS-CoV-2 main protease and inhibitor drug candidates.
32652766 2020. The link between Vitamin D and Covid-19: distinguishing facts from fiction.
32662708 2020. SARS-CoV-2 in the first trimester of pregnancy: potential interference in placentation.
32692176 2020. Lung protection by cathepsin C inhibition: a new hope for COVID-19 and ARDS?
32716073 2020. Vitamin D insufficiency as a potential culprit in critical COVID-19 patients.
32691896 2020. Hydroxychloroquine, dermatology, and SARS-CoV-2: Updating an old association.
32691875 2020. SARS-CoV-2 S1 is superior to the RBD as a COVID-19 subunit vaccine antigen.
32681650 2020. SARS-CoV-2 replicating in non-primate mammalian cells probably have critical advantages for COVID-19 vaccines due to anti-Gal antibodies: A minireview and proposals.
32672860 2020. Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study.
32658304 2020. Montelukast drug activity and potential against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
32651248 2020. Management of patients with generalised myasthenia gravis and COVID-19: four case reports.
32680924 2020. Oncology-inspired treatment options for COVID-19.
32710111 2020. Vitamin D and COVID-19: Lessons from Spaceflight Analogs.
32705690 2020. Benzothiazoles as potential antiviral agents.
32650355 2020. Antirheumatic drugs for COVID-19 treatment based on the phases of the disease: Current concept.
32699094 2020. Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
32675436 2020. Tailoring steroids in the treatment of COVID-19 pneumonia assisted by CT scans: Three case reports.
32717043 2020. Pooling Data From Individual Clinical Trials in the COVID-19 Era.
32662848 2020. COVID-19 Antibody Trials Have Begun.
32716474 2020. Setting Expectations for Clinical Research During the COVID-19 Pandemic.
32720612 2020. [Steroid pulse -therapy in patients With coronAvirus Pneumonia (COVID-19), sYstemic inFlammation And Risk of vEnous thRombosis and thromboembolism (WAYFARER Study)].
32702300 2020. Encouraging results from phase 1/2 COVID-19 vaccine trials.
32702299 2020. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial.
32663575 2020. Tackling the cytokine storm in COVID-19, challenges and hopes.
32720605 2020. In silico study to evaluate the antiviral activity of novel structures against 3C-like protease of Novel Coronavirus (COVID-19) and SARS-CoV.
32679430 2020. Eicosapentaenoic free fatty acid to treat patients with SARS-Cov2 infection.
32678815 2020. Lopinavir-ritonavir para COVID-19: una revision sistematica viva.
32721082 2020. A Computational Approach to Identify Potential Novel Inhibitors against the Coronavirus SARS-CoV-2.
32696772 2020. Repurposing drugs against the main protease of SARS-CoV-2: mechanism-based insights supported by available laboratory and clinical data.
32658332 2020. COVID-19 in MuSK Myasthenia Gravis: A Case Report.
32706953 2020. Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.
32706553 2020. Audio Interview: Dexamethasone and Covid-19.
32678530 2020. Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report.
32668131 2020. Audio Interview: Covid-19 Vaccine Development.
32668109 2020. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. Reply.
32668108 2020. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
32668107 2020. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
32668106 2020. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
32669667 2020. How computational immunology changed the face of COVID-19 vaccine development.
32651581 2020. Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein.
32669664 2020. COVID-19 vaccine development and a potential nanomaterial path forward.
32699321 2020. Controlling the SARS-CoV-2 spike glycoprotein conformation.
32661423 2020. Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.
32707573 2020. Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.
32698191 2020. Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.
32698190 2020. Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2.
32668443 2020. Potently neutralizing and protective human antibodies against SARS-CoV-2.
32694847 2020. Coronavirus vaccines get a biotech boost.
32667989 2020. COVID-19 and tobacco - more questions than answers.
32679589 2020. Supplementation with vitamin D in the COVID-19 pandemic?
32653930 2020. Dietary recommendations during the COVID-19 pandemic.
32677126 2020. Efficacy of povidone-iodine to reduce viral load.
32660339 2020. Intranasal Antiviral Drug Delivery and Coronavirus Disease 2019 (COVID-19): A State of the Art Review.
32677113 2020. The cardiovascular effects of treatment with hydroxychloroquine and azithromycin.
32674177 2020. Therapie mit Dexamethason bei Patienten mit COVID-19.
32674189 2020. DZK-Stellungnahme zu Tuberkulose, BCG und COVID-19.
32699149 2020. Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19.
32699147 2020. Opinion: It's ethical to test promising coronavirus vaccines against less-promising ones.
32662915 2020. Computer modelling of a potential agent against SARS-Cov-2 (COVID-19) protease.
32696570 2020. Tocilizumab therapy in individuals with COVID-19 infection and hyperinflammatory state.
32698247 2020. The effect of BCG vaccine in the era of COVID-19 pandemic.
32657436 2020. Can medicinal mushrooms have prophylactic or therapeutic effect against COVID-19 and its pneumonic superinfection and complicating inflammation?
32720847 2020. Is there really room for anti-rheumatic drugs in the treatment of COVID-19?
32690628 2020. An alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates.

32691006 2020. Dietary therapy and herbal medicine for COVID-19 prevention: A review and perspective.
32691005 2020. The antiviral and coronavirus-host protein pathways inhibiting properties of herbs and natural compounds - Additional weapons in the fight against the COVID-19 pandemic?
32650788 2020. Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development.
32682081 2020. Fish Oil and Covid-19 Thromboses.
32661140 2020. The SARS-CoV-2 N protein is a good component in a vaccine.
32687267 2020. Chloroquine and hydroxychloroquine for the prevention and therapy of COVID-19: new hopes and old cardiovascular concerns.
32702298 2020. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
32653520 2020. Computational insights into tetracyclines as inhibitors against SARS-CoV-2 M(pro) via combinatorial molecular simulation calculations.
32679150 2020. Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based meta-analysis.
32679148 2020. The bio-mission of interleukin-6 in the pathogenesis of COVID-19: A brief look at potential therapeutic tactics.
32684816 2020. Anti-inflammatory Properties of Stingless Bee Honey May Reduce the Severity of Pulmonary Manifestations in COVID-19 Infections?
32703911 2020. Can Dietary Fatty Acids Affect the COVID-19 Infection Outcome in Vulnerable Populations?
32663741 2020. Prospective vaccination of COVID-19 using shRNA-plasmid-LDH nanoconjugate.
32683221 2020. Immuno-pathogenesis of nCOVID-19 and a possible host-directed therapy including anti-inflammatory and anti-viral prostaglandin (PG J2) for effective treatment and reduction in the death toll.
32653736 2020. Surfactant-based prophylaxis and therapy against COVID-19: A possibility.
32683219 2020. Transpulmonary electrotherapy for reduction of lung viral load of SARS-CoV-2 in patients with COVID-19.
32670526 2020. Pidotimod in Paucisymptomatic SARS-CoV2 Infected Patients.
32668701 2020. High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2.
32663912 2020. An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.
32663910 2020. The Covid-19 Vaccine-Development Multiverse.
32665542 2020. Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing.
32661375 2020. Immune-mediated approaches against COVID-19.
32694244 2020. The Combined Use of Tocilizumab and Hemoadsorption in a Patient with SARS-COV-2-19-Associated Pneumonia: A Case Report.
32681986 2020. Harnessing nitric oxide for preventing, limiting and treating the severe pulmonary consequences of COVID-19.
32655899 2020. Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic.
32679784 2020. Immunologic Effects of Vitamin D on Human Health and Disease.
32691007 2020. Countermeasures to Coronavirus Disease 2019: Are Immunomodulators Rational Treatment Options-A Critical Review of the Evidence.
32671131 2020. Antiviral Activity and Safety of Darunavir/Cobicistat for the Treatment of COVID-19.
32704455 2020. Small molecule therapeutics for COVID-19: repurposing of inhaled furosemide.
32700247 2020. Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19.
32653650 2020. The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2.
32653649 2020. Analysis on the current quality standards of Chinese materia Medica used in COVID-19 prevention and treatment.
32675044 2020. Contribution of traditional Chinese medicine to the treatment of COVID-19.
32706790 2020. Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios.
32706783 2020. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation.
32701969 2020. Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease.
32661586 2020. COVID-19 and purinergic signaling: the need for investigation.
32702730 2020. In silico Drug Repurposing to combat COVID-19 based on Pharmacogenomics of Patient Transcriptomic Data.
32702732 2020. Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus Platform.
32702715 2020. Worldwide inverse correlation between Bacille Calmette-Guerin immunization and COVID-19 morbidity and mortality.
32702731 2020. Hospitalized COVID-19 Patients treated with Convalescent Plasma in a Mid-size City in the Midwest.
32670785 2020. Successful recovery from COVID-19 pneumonia after receiving baricitinib, tocilizumab, and remdesivir. A case report: Review of treatments and clinical role of computed tomography analysis.
32659271 2020. Pros and cons of corticosteroid therapy for COVID-19 patients.
32696884 2020. Effects of four types of integrated Chinese and Western medicines for the treatment of COVID-19 in China: a network meta-analysis.
32696862 2020. Use of remdesivir for patients with Covid-19: a review article.
32696811 2020. Long-term positive severe acute respiratory syndrome coronavirus 2 ribonucleic acid and therapeutic effect of antivirals in patients with coronavirus disease: Case reports.
32691011 2020. Structure-based drug designing and immunoinformatics approach for SARS-CoV-2.
32661235 2020. Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development.
32660307 2020. RNA-Dependent RNA Polymerase as a Target for COVID-19 Drug Discovery.
32695804 2020. Cellular Therapy: Shafts of Light Emerging for COVID-19.
32698898 2020. Mesenchymal stem cells: current clinical progress in ARDS and COVID-19.
32678017 2020. A synergistic role of convalescent plasma and mesenchymal stem cells in the treatment of severely ill COVID-19 patients: a clinical case report.
32696426 2020. Treatment of COVID-19 Pneumonia: the Case for Placenta-derived Cell Therapy.
32661867 2020. Mesenchymal Stem Cell Derived Exosomes: a Nano Platform for Therapeutics and Drug Delivery in Combating COVID-19.
32641644 2020. COVID-19 Pandemic: Can Maintaining Optimal Zinc Balance Enhance Host Resistance?
32653199 2020. Immunomodulation for the management of corona virus disease (COVID-19).
32631501 2020. Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?
32620409 2020. Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia.
32694044 2020. Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma.
32694043 2020. Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study.
32684483 2020. A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a Framework for Accelerated Synthesis of Trial Evidence-FAST Evidence.
32660611 2020. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
32682360 2020. The use of hydroxychloroquine plus azithromycin and early hospital admission are beneficial in Covid-19 patients: Turkey experience with real-life data.
32654907 2020. Bacillus Calmette-Guerin vaccine, antimalarial, age and gender relation to COVID-19 spread and mortality.
32653276 2020. The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines.
32620375 2020. Contingent assessment of the COVID-19 vaccine.
32684499 2020. Planning for COVID-19 vaccines safety surveillance.
32698423 2020. Identification and Analysis of Unstructured, Linear B-Cell Epitopes in SARS-CoV-2 Virion Proteins for Vaccine Development.
32664505 2020. Significantly Improved COVID-19 Outcomes in Countries with Higher BCG Vaccination Coverage: A Multivariable Analysis.
32666898 2020. Images in Vascular Medicine: Peripheral artery thrombosis in critically ill patients with COVID-19.
32691699 2020. Antimalarial and cytotoxic drugs on COVID-19 and the cardiovascular burden: Literature review and lessons to be learned.
32696396 2020. A Small-Scale Medication of Leflunomide as a Treatment of COVID-19 in an Open-Label Blank-Controlled Clinical Trial.
32698440 2020. Tiotropium is Predicted to be a Promising Drug for COVID-19 Through Transcriptome-Based Comprehensive Molecular Pathway Analysis.

head
32718713 ?. Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience.
C7334972 ?. Hydroxychloroquine in the treatment of COVID-19: How to use it waiting for conclusive scientific evidence?.
C7242950 2020. Use of antimalarial drugs in the treatment of COVID-19: A window of opportunity??.
C7303026 2020. ET-traps as a potential treatment for COVID-19.
C7266578 ?. Vitamin D Levels and COVID-19 Susceptibility: Is there any Correlation?
C7255206 ?. BCG vaccination strategy implemented to reduce the impact of COVID-19: Hype or Hope?
C7227543 2020. COVID-19 lockdown: de-risking exit by protecting the lung with leukaemia inhibitory factor (LIF).
32721804 2020. Recombinant protein targeting and opsonizing spike glycoprotein for enhancing SARS-CoV-2 phagocytosis.
32683222 2020. The immunomodulatory effects of exercise against COVID-19.
32663741 2020. Prospective vaccination of COVID-19 using shRNA-plasmid-LDH nanoconjugate.
32683221 2020. Immuno-pathogenesis of nCOVID-19 and a possible host-directed therapy including anti-inflammatory and anti-viral prostaglandin (PG J2) for effective treatment and reduction in the death toll.
C7340056 2020. Ibuprofen a traditional drug that may impact the course of COVID-19 new effective formulation in nebulizable solution.
32683219 2020. Transpulmonary electrotherapy for reduction of lung viral load of SARS-CoV-2 in patients with COVID-19.
C7321662 2020. Reposition of montelukast either alone or in combination with levocetirizine against SARS-CoV-2.
C7320867 2020. Rethinking interleukin-6 blockade for treatment of COVID-19.
C7320853 2020. Doxycycline or minocycline may be a viable treatment option against SARS-CoV-2.
C7319607 2020. Why the lower reported prevalence of asthma in patients diagnosed with COVID-19 validates repurposing EDTA solutions to prevent and manage treat COVID-19 disease.
C7318945 2020. Cytochrome P450-mediated drug interactions in COVID-19 patients: Current findings and possible mechanisms.
C7309834 2020. Towards a pharmacochemical hypothesis of the prophylaxis of SARS-CoV-2 by psychoactive substances.
C7301797 2020. Statins may be a key therapeutic for Covid-19.
C7261222 ?. Evaluating the potential of different inhibitors on RNA-dependent RNA polymerase of severe acute respiratory syndrome coronavirus 2: A molecular modeling approach.
C7240261 ?. Spectral domain optical coherence tomography?based prevalence of hydroxychloroquine maculopathy in Indian patients on hydroxychloroquine therapy: A utopia of underdiagnosis.
32670526 2020. Pidotimod in Paucisymptomatic SARS-CoV2 Infected Patients.
32670525 2020. Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure.
32661375 ?. Immune-mediated approaches against COVID-19.
C7313782 ?. Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19.
C7276122 ?. Remdesivir investigational trials in COVID-19: a critical reappraisal.
C7303619 ?. Re. Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol.
C7313521 2020. COVID-19 and the rush for self-medication and self-dosing with ivermectin: A word of caution.
C7337805 ?. Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19.
C7313774 ?. Countermeasures to COVID-19: Are immunomodulators rational treatment options ? a critical review of the evidence.
C7294877 ?. Quest for a COVID-19 Cure by Repurposing Small-Molecule Drugs: Mechanism of Action Clinical Development Synthesis at Scale and Outlook for Supply.
C7294886 ?. Development of a Large-Scale Cyanation Process Using Continuous Flow Chemistry En Route to the Synthesis of Remdesivir.
C7347483 ?. Potential influence of Nagella sativa (Black Cumin) in reinforcing immune system: a hope to decelerate the COVID-19 pandemic.
32675044 ?. Contribution of traditional Chinese medicine to the treatment of COVID-19.
C7211506 ?. Phytochemicals as Antiviral Agents: Recent Updates.
C7267043 2020. Topological Indices of Some Chemical Structures Applied for the Treatment of COVID-19 Patients.
C7341047 ?. Psychiatric Aspects of Chloroquine and Hydroxychloroquine Treatment in the Wake of COVID-19: Psychopharmacological Interactions and Neuropsychiatric Sequelae.
32661586 ?. COVID-19 and purinergic signaling: the need for investigation.
C7256487 ?. Ethical rationale for better coordination of clinical research on COVID-19.
32702719 ?. COVID-19: Famotidine Histamine Mast Cells and Mechanisms .
32702734 ?. Potentially repurposable drugs for COVID-19 identified from SARS-CoV-2 Host Protein Interactome.
32702713 ?. An in-silico approach to develop of a multi-epitope vaccine candidate against SARS-CoV-2 envelope (E) protein.
32702733 ?. A Novel RP-HPLC-DAD Method Development for Anti-Malarial and COVID-19 Hydroxy Chloroquine Sulfate Tablets and Profiling of In-Vitro Dissolution in Multimedia. .
32702077 ?. Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS .
C7255263 2020. Use of corticosteroids in asthma and COPD patients with or without COVID-19.
C7308754 2020. Efficacy and safety of tocilizumab in critically ill adults with COVID-19 infection in Bahrain: A report of 5 cases.
32659271 2020. Pros and cons of corticosteroid therapy for COVID-19 patients.
32703528 ?. Réplica: Ivermectina en COVID-19. ¿Argumentum ad ignorantiam?
C7328629 2020. Hypothèse en Asie : protection du Covid et vaccin anti-encéphalite ?
C7305479 2020. 5-(Perylen-3-ylethynyl)uracil Derivatives Inhibit Reproduction of Respiratory Viruses.
C7286259 ?. In silico screening of FDA approved drugs reveals ergotamine and dihydroergotamine as potential coronavirus main protease enzyme inhibitors.
C7319274 ?. Structure-based drug designing and immunoinformatics approach for SARS-CoV-2.
32718560 ?. Desperate Times Desperate Measures: The Case for RRx-001 in the Treatment of COVID-19.
C7255217 ?. Reply to Delirium sleep COVID-19 and melatonin .
C7351559 ?. Can HCQ Be Considered a ?Safe Weapon? for COVID-19 in the Indian Population?
C7340747 ?. Ozone (O3) and SARS-CoV-2: Physiological Bases and Their Therapeutic Possibilities According to COVID-19 Evolutionary Stage.
C7320242 ?. Ventricular Arrhythmia Risk Based on Ethnicity in COVID-19 Patients on Hydroxychloroquine and Azithromycin Combination: Viewpoint.
32661867 ?. Mesenchymal Stem Cell Derived Exosomes: a Nano Platform for Therapeutics and Drug Delivery in Combating COVID-19.
32669846 2020. Major Neurologic Adverse Drug Reactions Potential Drug?Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review.
C7301821 2020. Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population consider N-acetylcysteine as early therapeutic intervention.
32694044 ?. Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma.
C7283069 ?. Convalescent plasma from COVID 19 patients enhances intensive care unit survival rate. A preliminary report.
32703664 ?. International Survey of Trials of Convalescent Plasma to Treat COVID-19 Infection.
32684483 ?. A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a Framework for Accelerated Synthesis of Trial Evidence?FAST Evidence.
C7276128 2020. Compressed fluids and phytochemical profiling tools to obtain and characterize antiviral and anti-inflammatory compounds from natural sources.
32654907 2020. Bacillus Calmette?Guérin vaccine antimalarial age and gender relation to COVID-19 spread and mortality.
C7293477 ?. A review on Promising vaccine development progress for COVID-19 disease.
C7245990 ?. Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor.
C7315151 2020. Hydroxychloroquine retinal toxicity: The bull s eye in the human eye.
C7287468 2020. Exploration on the feasibility of moxibustion in prevention and treatment of COVID-19 from the perspective of modern medical mechanism.
C7272237 ?. Homeopathy combat against coronavirus disease (Covid-19). head
32674928 2020. Review of: ?Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010 DOI:10.1016/j.ijantimicag.2020.105949.
32674929 2020. Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?
32679328 2020. Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vaccines.
C7292951 2020. Tandem mass spectrometry of small-molecule antiviral drugs: 3. antiviral agents against herpes influenza and other viral infections.
C7335489 2020. A consensus guideline of herbal medicine for coronavirus disease 2019.
C7328533 2020. Herbal medicine for the management of COVID-19 during the medical observation period: A review of guidelines.
C7326427 2020. Allium fistulosum congee as a home remedy to ward off the corona virus at an early stage.
C7323643 2020. COVID-19 ? Where should we go now?
C7311349 2020. The potential benefits of Chinese integrative medicine for pregnancy women during the COVID-19 pandemic.
C7280829 2020. The evaluation of online course of Traditional Chinese Medicine for MBBS international students during the COVID-19 epidemic period.
C7262361 ?. COVID?19: A review of therapeutics under investigation.
32674834 2020. Plasma Therapies and Parabiosis in the COVID-19 Era.
C7263178 ?. The COVID 19 novel coronavirus pandemic 2020: seaweeds to the rescue? Why does substantial supporting research about the antiviral properties of seaweed polysaccharides seem to go unrecognized by the pharmaceutical community in these desperate times?
32713677 ?. Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients.
32680602 ?. Ayurvedic treatment of COVID-19/SARS-CoV-2: A case report.
C7309301 2020. Leucoefdin a potential inhibitor against SARS CoV-2 Mpro.
32661214 2020. Drug targets for COVID-19 therapeutics: Ongoing global efforts.
32659363 ?. Achieving Effective Informed Oversight by DMCs in COVID Clinical Trials.
32682805 ?. Are statins safe in patients with COVID-19?
32683212 2020. Update I. A systematic review on the efficacy and safety of chloroquine/hydroxychloroquine for COVID-19.
C7261216 ?. Drug repurposing using computational methods to identify therapeutic options for COVID-19.
32680687 ?. Therapeutic plasma exchange in life-threatening COVID-19 and associated cytokine release syndrome.
C7313527 2020. Potential benefits of combination of Nigella sativa and Zn supplements to treat COVID-19.
32684351 ?. An overview of the safety clinical application and antiviral research of the COVID-19 therapeutics.
32670898 2020. Increasing Immunity to Fight against Novel COVID-19: Noninvasive Public Health Approach.
C7323248 ?. Hydroxychloroquine treatment in COVID?19: a descriptive observational analysis of 30 cases from a single center in Wuhan China.
C7297697 2020. Immunoinformatics characterization of SARS-CoV-2 spike glycoprotein for prioritization of epitope based multivalent peptide vaccine.
C7347502 2020. Inhibition of SARS-CoV-2 main protease 3CLpro by means of ?-ketoamide and pyridone-containing pharmaceuticals using in silico molecular docking.
C7334662 2020. Computational evaluation of major components from plant essential oils as potent inhibitors of SARS-CoV-2 spike protein.
C7309803 2020. Azafluorene derivatives as inhibitors of SARS CoV-2 RdRp: Synthesis physicochemical quantum chemical modeling and molecular docking analysis.
C7266611 2020. Inhibitory activity of hydroxychloroquine on COVID-19 main protease: An insight from MD-simulation studies.
C7293167 ?. Is Vitamin D One of the Key Elements in COVID-19 Days?
C7256177 ?. Nutritional Considerations in Frail Older Patients with COVID-19.
C7319620 ?. Use of subcutaneous tocilizumab to prepare intravenous solutions for COVID-19 emergency shortage: Comparative analytical study of physicochemical quality attributes.
C7260602 2020. Dietary therapy and herbal medicine for COVID-19 prevention: A review and perspective.
C7260130 2020. The antiviral and coronavirus-host protein pathways inhibiting properties of herbs and natural compounds - Additional weapons in the fight against the COVID-19 pandemic?
32405422 2020. Review of safety and minimum pricing of nitazoxanide for potential treatment of COVID-19.
C7331548 2020. Minimum costs to manufacture new treatments for COVID-19.
C7331506 2020. A review of the safety of favipiravir ? a potential treatment in the COVID-19 pandemic?
C7331563 2020. Summary of the coronavirus disease 2019 (COVID-19) update from the 2020 Conference on Retroviruses and Opportunistic Infections 8?11 March 2020 Boston USA.
C7296301 2020. Acute Cor Pulmonale in COVID-19-Related ARDS: Improvement With Almitrine Infusion.
C7354765 ?. Hydroxychloroquine-associated Hypoglycemia in Hemodialysis Patients with COVID-19.
C7298510 ?. Steroids: A Therapeutic Option for COVID-19 Pneumonia Patients With ESRD?
32673604 2020. Probiotics and COVID-19.
32673605 2020. Probiotics and COVID-19 ? Authors reply.
32673603 2020. Probiotics and COVID-19.
C7333995 2020. Development of potential COVID-19 vaccines continues to accelerate.
C7351406 ?. Iloprost for COVID-19-related vasculopathy.
C7316462 2020. Anakinra for patients with COVID-19.
C7316458 2020. Anakinra for patients with COVID-19.
C7316448 2020. Anakinra for patients with COVID-19.
C7316444 2020. Anakinra for patients with COVID-19 ? Authors reply.
C7314456 2020. Tocilizumab in patients with severe COVID-19: a retrospective cohort study.
C7314441 2020. Can tocilizumab calm the cytokine storm of COVID-19?
C7272172 2020. Canakinumab in a subgroup of patients with COVID-19.
C7259909 2020. Anakinra for severe forms of COVID-19: a cohort study.
C7241987 2020. Anakinra in COVID-19: important considerations for clinical trials.
C7239618 2020. The immunology of COVID-19: is immune modulation an option for treatment?
C7328610 2020. Calming the Cytokine Storm in Pneumonia by Biomimetic Nanoparticles.
C7242942 2020. Calming Cytokine Storm in Pneumonia by Targeted Delivery of TPCA-1 Using Platelet-Derived Extracellular Vesicles.
C7275157 2020. Clinical Trial End Points in Severe COVID-19.
C7275153 2020. Vitamin D Supplementation During the COVID-19 Pandemic.
C7275146 2020. Famotidine Against SARS-CoV2: A Hope or Hype?
C7237942 2020. Acute QT Interval Modifications During Hydroxychloroquine-Azithromycin Treatment in the Context of COVID-19 Infection.
C7334919 ?. Deficiencies in the Designs and Interventions of COVID-19 Clinical Trials.
C7235585 ?. Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial.
C7351402 ?. Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia.
32718719 ?. Interacciones medicamentosas potenciales en pacientes COVID 19 en tratamiento con lopinavir/ritonavir.
32718715 ?. Reacciones adversas a fármacos utilizados en el tratamiento específico de la infección por SARS-CoV-2.
C7346829 ?. Agentes terapéuticos utilizados en 238 pacientes hospitalizados por COVID-19 y su relación con la mortalidad.
C7332949 ?. Abordaje terapéutico del SARS-CoV-2 (COVID-19) mediante células mesenquimales de médula ósea alogénica expandidas. Conceptos a propósito de un primer caso en España.
C7351423 ?. Effectiveness of corticoid pulses in patients with cytokine storm syndrome induced by SARS-CoV-2 infection?.

32167678 2020. Evaluation of glycoprotein E subunit and live attenuated varicella-zoster virus vaccines formulated with a single-strand RNA-based adjuvant.
32405233 2020. The Promise and Peril of Natural Killer Cell Therapies in Pulmonary Infection.
32400027 2020. Immunological fortification at our barrier organs: Protecting us as we age.
25762305 2015. Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus.
32621997 2020. Which QTc correction formulae (Bazett, Framingham, or Fridericia) to use for Hydroxychloroquine induced QTc prolongation?
32621996 2020. HCQ induced QT prolongation- Primum non nocere.
32651941 2020. That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19.
32645630 2020. Evaluation of safety, efficacy, tolerability, and treatment-related outcomes of type I interferons for human coronaviruses (HCoVs) infection in clinical practice: An updated critical systematic review and meta-analysis.
32430515 2020. Glucocorticoids inhibit type I IFN beta signaling and the upregulation of CD73 in human lung.
32654006 2020. Emerging pharmacological therapies for ARDS: COVID-19 and beyond.
32303896 2020. Therapeutic and prophylactic potential of anti-microbial peptides against coronaviruses.
32622261 2020. Current Status of COVID-19 Therapies and Drug Repositioning Applications.
32652194 2020. Retrospective Analysis of Dermatological Adverse Events Associated with Hydroxychloroquine Reported to the United States Food and Drug Administration.
32339702 2020. Role of phototherapy in the era of biologics.
32622513 2020. The roles of PPARgamma and its agonists in autoimmune diseases: A comprehensive review.
32624376 2020. Ayurvedic clinical profile of COVID-19 - A preliminary report.
32637368 2020. COVID-19: Introducing Low Dose Radiation as an Effective Treatment for Pneumonia that Shouldn't Induce Selective Pressure and New Mutations.
32375574 2020. Repurposing of chloroquine and some clinically approved antiviral drugs as effective therapeutics to prevent cellular entry and replication of coronavirus.
32306854 2020. Novel guanosine derivatives against MERS CoV polymerase: An in silico perspective.
18442051 2008. Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): in search of potent SARS-CoV entry inhibitors.
32655741 2020. First Reported Use of Highly Adsorptive Hemofilter in Critically Ill COVID-19 Patients in the USA.
32617428 2020. Statins as early therapy to mitigate COVID-19 (SARS-CoV-2)-associated ARDS and cytokine storm syndrome - time is of the essence.
15693056 2005. SARS-CoV protease inhibitors design using virtual screening method from natural products libraries.
32594451 2020. Efficacy and safety of hydroxychloroquine as add-on therapy in uncontrolled type 2 diabetes patients who were using two oral antidiabetic drugs.
32535155 2020. The stress-inducible molecular chaperone GRP78 as potential therapeutic target for coronavirus infection.
32652164 2020. Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis.
28864360 2018. Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): A review.
32654098 2020. QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin.
18324609 2008. Metabolite identification of arbidol in human urine by the study of CID fragmentation pathways using HPLC coupled with ion trap mass spectrometry.
32398885 2020. How materials can beat a virus.
32398884 2020. Materials Science in the time of Coronavirus.
32410212 2020. Acute kidney injury is associated with the mortality of coronavirus disease 2019.
32628003 2020. Tocilizumab in patients with severe COVID-19: A single-center observational analysis.
32617527 2020. Whole Genome Analysis and Targeted Drug Discovery Using Computational Methods and High Throughput Screening Tools for Emerged Novel Coronavirus (2019-nCoV).
32301512 2020. Drug repositioning: a brief overview.
32653646 2020. SARS-CoV and SARS-CoV-2 main protease residue interaction networks change when bound to inhibitor N3.
32624302 2020. A case of cytokine hemofiltration and extracorporeal life support as treatment of coronavirus disease 2019 (COVID-19) respiratory failure.
32642277 2020. Hydrogen/oxygen mixed gas inhalation improves disease severity and dyspnea in patients with Coronavirus disease 2019 in a recent multicenter, open-label clinical trial.
32642225 2020. Addressing the "What do we have to lose? Just give the drug" rationale: making the case for clinical trials and against off-label use in COVID-19.
32576276 2020. "Right-to-Try" experimental drugs: an overview.
32650788 2020. Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development.
32188729 2020. Coronavirus Endoribonuclease and Deubiquitinating Interferon Antagonists Differentially Modulate the Host Response during Replication in Macrophages.
18199635 2008. Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge.
32493486 2020. Alveolar lipids in pulmonary disease. A review.
32653736 2020. Surfactant-based prophylaxis and therapy against COVID-19: A possibility.
32423569 2020. Del empirismo a la evidencia cientifica en el tratamiento con antiviricos en los casos graves de infeccion por coronavirus en tiempos de epidemia.
32599077 2020. Coronavirus vaccine-associated lung immunopathology-what is the significance?
32600307 2020. The alpha7 nicotinic acetylcholine receptor agonist, GTS-21, attenuates hyperoxia-induced acute inflammatory lung injury by alleviating the accumulation of HMGB1 in the airways and the circulation.
32579882 2020. Preparing for Pandemics: RNA Vaccines at the Forefront.
32516954 2020. Antiviral Effects of Plant-Derived Essential Oils and Their Components: An Updated Review.
32325742 2020. Advances on Antiviral Activity of Morus spp. Plant Extracts: Human Coronavirus and Virus-Related Respiratory Tract Infections in the Spotlight.
32295300 2020. Natural Bioactive Compounds from Fungi as Potential Candidates for Protease Inhibitors and Immunomodulators to Apply for Coronaviruses.
32459913 2020. Remdesivir - An Important First Step.
32409740 2020. Type I and type III interferon in opposition?
32636478 2020. Dexamethasone to the rescue.
32378128 2020. Drug repurposing in cardiology.
32651844 2020. The 'president's drug'.
32643072 2020. An antiarrhythmic approach to hydroxychloroquine-induced QT prolongation.
32474177 2020. Nicotinic acetylcholine receptors regulate clustering, fusion and acidification of the rat brain synaptic vesicles.
32529044 2020. Better patient identification could help fight the coronavirus.
32655899 2020. Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic.
32579137 2020. New international guidance on quality, safety and efficacy of DNA vaccines.
32579135 2020. WHO informal consultation on the guidelines for evaluation of the quality, safety, and efficacy of DNA vaccines, Geneva, Switzerland, December 2019.
32536809 2020. Is a vitamin D fortification strategy needed?
32349265 2020. Vitamin D and Immunity in Infants and Children.
32344708 2020. A Novel Combination of Vitamin C, Curcumin and Glycyrrhizic Acid Potentially Regulates Immune and Inflammatory Response Associated with Coronavirus Infections: A Perspective from System Biology Analysis.
32325790 2020. Key Vitamin D Target Genes with Functions in the Immune System.
32325778 2020. Effects of an Omega-3 and Vitamin D Supplement on Fatty Acids and Vitamin D Serum Levels in Double-Blinded, Randomized, Controlled Trials in Healthy and Crohn's Disease Populations.
32290296 2020. The Role of Selenium in Health and Disease: Emerging and Recurring Trends.
32617169 2020. Hydroxychloroquine-induced Stevens-Johnson syndrome in COVID-19: a rare case report.
32551127 2020. Covering coronavirus-emerging tools for the fight against the common enemy.
32653463 2020. Vaccines for COVID-19: The current state of play.
32630514 2020. Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection.
32590098 2020. Global research on artemisinin and its derivatives: Perspectives from patents.
32653650 2020. The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2.
32653649 2020. Analysis on the current quality standards of Chinese materia Medica used in COVID-19 prevention and treatment.
32384116 2020. Characterization of a human monoclonal antibody generated from a B-cell specific for a prefusion-stabilized spike protein of Middle East respiratory syndrome coronavirus.
32350142 2020. News Feature: To counter the pandemic, clinicians bank on repurposed drugs.
17567736 2007. Crystallographic studies of the complexes of antiviral protein griffithsin with glucose and N-acetylglucosamine.
17340634 2007. Crystallographic, thermodynamic, and molecular modeling studies of the mode of binding of oligosaccharides to the potent antiviral protein griffithsin.
32540609 2020. Possible beneficial role of throat gargling in the coronavirus disease pandemic.
32653040 2020. The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19.
32616298 2020. Ivermectina en COVID-19. inverted question markArgumentum ad ignorantiam?
32636066 2020. Electrocardiographic/QT interval monitoring with a portable device in hospitalized patients with COVID-19: a protocol proposal.
32593625 2020. Melatonin, coronavirus, cardiovascular disease, and the geriatric emergency: let's use everything we have!
32622732 2020. The presence of heart disease worsens prognosis in patients with COVID-19.
32550880 2020. Recommandations EMA sur l'usage compassionnel du remdesivir.
32537031 2020. Hochdosiertes Chloroquin bei COVID-19 gefahrlich.
32577525 2020. A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques.
32179788 2020. Ginkgolic acid inhibits fusion of enveloped viruses.
32448377 2020. Stem cell therapy: a potential approach for treatment of influenza virus and coronavirus-induced acute lung injury.
32318958 2020. How to "Detronize" Virus in Crown - Questions to Current Stem Cell Therapies.
32537523 2020. An aurora of natural products-based drug discovery is coming.
32612804 2020. Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents.
32641977 2020. Bioengineering tools to speed up the discovery and preclinical testing of vaccines for SARS-CoV-2 and therapeutic agents for COVID-19.
32653199 2020. Immunomodulation for the management of corona virus disease (COVID-19).
32631501 2020. Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?
32620409 2020. Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia.
32636114 2020. Extracorporeal blood purification treatment options for COVID-19: The role of immunoadsorption.
32565057 2020. The true historical origin of convalescent plasma therapy.
32542716 2020. Effective coronavirus reduction by various production steps during the manufacture of plasma-derived medicinal products.
32333396 2020. Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light.
32533558 2020. Convalescent plasma - this is no time for competition.
24117799 2014. Pathogen inactivation and removal methods for plasma-derived clotting factor concentrates.
32504825 2020. Innovative highlights of clinical drug trial design.
32593869 2020. Traditional Chinese Herbal Medication for corona-virus 2019.
32340868 2020. Improving Vaccine-Induced Immunity: Can Baseline Predict Outcome?
32651113 2020. Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates.
32313527 2020. Vacunas contra el coronavirus.
32395638 2020. Chloroquine/Hydroxychloroquine Overdose.
32240549 2020. Pivotal role of convalescent plasma in managing emerging infectious diseases.
12800213 2003. Advances in clinical diagnosis and treatment of severe acute respiratory syndrome. head
C7357981 ?. Artemisia and COVID-19.
C7261228 ?. Vitamin D and COVID-19.
C7234785 ?. Anti-SARS-CoV-2 hyperimmune immunoglobulins an urgent strategic choice.
C7345415 2020. Isolation and characterization of an exopolymer produced by Bacillus licheniformis: In vitro antiviral activity against enveloped viruses.
C7340049 2020. A review for natural polysaccharides with anti-pulmonary fibrosis properties which may benefit to patients infected by 2019-nCoV.
C7336955 2020. Sulfated polymannuroguluronate TGC161 ameliorates leukopenia by inhibiting CD4+ T cell apoptosis.
C7275151 ?. Development of an Inactivated Vaccine Candidate BBIBP-CorV with Potent Protection against SARS-CoV-2.
32668216 2020. Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice.
C7276303 2020. Identification of SARS-CoV-2 Vaccine Epitopes Predicted to Induce Long-Term Population-Scale Immunity.
32693256 2020. Efficient degradation of chloroquine drug by electro-Fenton oxidation: Effects of operating conditions and degradation mechanism.
C7315147 2020. SYSTEMATIC REVIEW OF THE ONGOING CLINICAL TRIALS EVALUATING THE DIAGNOSTIC AND THERAPEUTIC INTERVENTIONS TO MANAGE THE RESPIRATORY INFECTION CAUSED BY 2019 NOVEL CORONAVIRUS (2019-NCOV).
C7343649 ?. Traditional Chinese medicine played a crucial role in battling COVID-19.
C7266592 ?. Carry forward advantages of traditional medicines in prevention and control of outbreak of COVID-19 pandemic.
C7351116 2020. Electron beam irradiation on novel coronavirus (COVID-19): A Monte?Carlo simulationProject supported by the National Natural Science Foundation of China (Grant No. 61901360).
C7292799 ?. Process integration for emerging challenges: optimal allocation of antivirals under resource constraints.
C7303657 ?. Systemic steroids and risk of fecal-oral shedding and increased transmission of SARS-Cov-2 in pemphigus cases???.
32663514 2020. Intestinal microbiome transfer a novel therapeutic strategy for COVID-19 induced hyperinflammation?: In reply to ?COVID-19: Immunology and treatment options? Felsenstein Herbert McNamara et al. 2020?.
C7314231 ?. Targeting complement in severe Coronavirus disease 2019 to address microthrombosis.
32682684 ?. Successful Use of COVID-19 Convalescent Plasma in a Patient Recently Treated for Follicular Lymphoma.
32727701 ?. Attenuated Novel SARS Coronavirus 2 Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient on Ruxolitinib.
32690179 2020. The key role of zinc in elderly immunity: A possible approach in the COVID-19 crisis.
32690172 2020. Foodomics and COVID-19.
32690158 2020. Home medical nutrition during SARS-CoV-2 pandemic ? A position paper.
C7128574 2020. New thinking in the treatment of 2019 novel coronavirus pneumonia.
C7282787 2020. The combined therapy of a traditional Chinese medicine formula and Western medicine for a critically ill case infected with COVID-19.
32658735 2020. Identification of potential inhibitors of three key enzymes of SARS-CoV2 using computational approach.
32658736 2020. Bioinformatics studies on a function of the SARS-CoV-2 spike glycoprotein as the binding of host sialic acid glycans.
32664990 2020. Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study.
32696008 2020. The Combination of Tocilizumab and Methylprednisolone Along With Initial Lung Recruitment Strategy in Coronavirus Disease 2019 Patients Requiring Mechanical Ventilation: A Series of 21 Consecutive Cases.
32696001 2020. Less Can Be More When Targeting Interleukin-6-Mediated Cytokine Release Syndrome in Coronavirus Disease 2019.
32696006 2020. Corticosteroid Administration Is Associated With Improved Outcome in Patients With Severe Acute Respiratory Syndrome Coronavirus 2-Related Acute Respiratory Distress Syndrome.
32661859 ?. Can Vitamins as Epigenetic Modifiers Enhance Immunity in COVID-19 Patients with Non-communicable Disease?
C7302922 ?. COVID-19 Drug Treatment in China.
32665127 ?. Are we fully exploiting type I Interferons in today s fight against COVID-19 pandemic?
C7323099 ?. Hydroxychloroquine for COVID?19: Myths vs Facts.
32683320 2020. Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19).
C7356495 ?. Traditional Chinese Medicine and Clinical Pharmacology.
C7229886 ?. Data Monitoring for the Chinese Clinical Trials of Remdesivir in Treating Patients with COVID-19 During the Pandemic Crisis.
C7238396 ?. Within a large healthcare system the incidence of positive COVID-19 results and mortality are lower in patients on chronic hydroxychloroquine therapy.
C7348610 ?. Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study.
C7329292 2020. Subcutaneous tocilizumab treatment in patients with severe COVID-19?related cytokine release syndrome: An observational cohort study.
32632415 2020. Endpoints used in phase III randomized controlled trials of treatment options for COVID-19.
32632410 2020. Serosurveys and convalescent plasma in COVID-19.
C7332434 ?. The Efficacy and Safety of Triazavirin for COVID-19: A Trial Protocol.
C7284238 ?. Mesenchymal Stem Cells Represent a Potential Therapeutic Option for Coronavirus Disease 2019-Related Acute Respiratory Distress Syndrome.
C7309930 2020. Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19.
C7329119 2020. Special issues raised by evolving areas of clinical research.
C7298480 2020. Ethical issues related to the hydroxychloroquine treatment prescription for Covid-19.
C7337728 ?. COVID-19 treatment with lopinavir?ritonavir resulting in sick sinus syndrome: a case report.
32670297 2020. Severe COVID-19: NLRP3 Inflammasome Dysregulated.
32670273 2020. Battling COVID-19 Pandemic: Sphingosine-1-Phosphate Analogs as an Adjunctive Therapy?
32670071 2020. Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy.
32670091 2020. The Modulation of Mucosal Antiviral Immunity by Immunobiotics: Could They Offer Any Benefit in the SARS-CoV-2 Pandemic?
32662664 ?. N-acetylcysteine as a potential treatment for novel coronavirus disease 2019.
32685190 ?. Better preventing and mitigating the effects of Covid-19.
C7295248 ?. Possible SARS-coronavirus 2 inhibitor revealed by simulated molecular docking to viral main protease and host toll-like receptor.
C7249572 ?. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection: let the virus be its own demise.
C7243912 ?. Virtual screening of immunomodulatory medicinal compounds as promising anti-SARS-COV-2 inhibitors.
C7324924 2020. mTOR inhibition and p53 activation microRNAs: The possible therapy against pandemic COVID-19.
C7305491 ?. Known drugs and small molecules in the battle for COVID-19 treatment.
C7345387 ?. Chloroquine kills hair cells in zebrafish lateral line and murine cochlear cultures: Implications for ototoxicity.
C7289101 ?. QT Interval and Arrhythmic Safety of Hydroxychloroquine Monotherapy in Coronavirus Disease 2019.
C7318948 2020. Early use of tocilizumab in respiratory failure associated with acute COVID -19 pneumonia in recipients with solid organ transplantation.
32659267 2020. Intermittent fasting a possible priming tool for host defense against SARS-CoV-2 infection: Crosstalk among calorie restriction autophagy and immune response.
C7351562 ?. Obesity and COVID-19: A Fatal Alliance.
C7347658 ?. Novel Stem Cells and Nucleic Acid-Based Vaccine Trials Against Viral Outbreak: A Systematic Evaluation During COVID-2019 Pandemic.
C7217267 ?. Does the Bacillus Calmette?Guérin vaccine provide protection from COVID-19?
C7217270 ?. Role of poly (ADP) ribose polymerase-1 inhibition by nicotinamide as a possible additive treatment to modulate host immune response and prevention of cytokine storm in COVID-19.
C7239502 ?. Modified Bhramari Pranayama in Covid 19 Infection.
C7279711 ?. Letter to the Editor: Acharya Prafulla Chandra Ray Hydroxychloroquine and COVID-19.
32656668 ?. SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in ?lasso? for the multi-faced virus.
C7351674 2020. Structure-based drug designing towards the identification of potential anti-viral for COVID-19 by targeting endoribonuclease NSP15. head
C7348117 2020. Remdesivir: Various toxicities: 4 case reports.
C7348113 2020. Multiple drugs interaction: Reduction in drug level and QTc prolongation following off label use: 2 case reports.
C7348108 2020. Tocilizumab: Neutropenia: case report.
C7348103 2020. Hydroxychloroquine: Acute haemolysis that lead to acute renal failure: case report.
C7348100 2020. Multiple drugs: Bradycardia atrioventricular block and off-label use: case report.
C7346767 2020. The use of corticosteroids for COVID-19 infection.
C7334124 2020. Azithromycin/hydroxychloroquine/propofol: Hypoglycaemia and cardiotoxicities following off label use: 2 case reports.
C7334118 2020. Hydroxychloroquine: Corrected QT interval prolongation first degree atrioventricular block and left bundle branch block during an off-label treatment with hydroxychloroquine for COVID-19 pneumonia: 3 case reports.
C7334116 2020. Etanercept/methotrexate: COVID-19: case report.
C7334127 2020. Hydroxychloroquine: QTc prolongation following off-label-use: case report.
C7334107 2020. Azithromycin/hydroxychloroquine: QT prolongation with a notched broad T-wave following off-label therapy: case report.
C7317081 2020. New potential interaction with emergency COVID-19 medicine remdesivir.
C7302795 2020. Bréve : Chloroquine OTC : danger !
C7296892 2020. COVID-19: Wirksamkeit integrativer Medizin?
C7284681 ?. Risiken und Chancen von Immuntherapien in Zeiten der Coronavirus-2019-Pandemie.
C7284280 ?. Los antimaláricos (cloroquina e hidroxicloroquina) en la pandemia COVID-19.
C7295303 2020. Emerging Treatment and Prevention Strategies against COVID-19: A Brief Update.
C7295283 2020. Exploring COVID-19 Therapies: An Extraordinary Global Challenge.
C7339112 2020. Azithromycin ? An Antibiotic to Fight COVID-19?
C7339103 2020. Hydroxychloroquine ? An Antimalarial to Fight COVID-19?
C7339105 2020. ?-Ketoamide Inhibitors of SARS-CoV-2 Main Protease.
C7239187 ?. Potential role of oral rinses targeting the viral lipid envelope in SARS-CoV-2 infection.
C7212254 2020. Abemaciclib/fulvestrant: Leucopenia and Covid-19: case report.
C7212250 2020. Prednisone: Coronavirus disease 2019: case report.
C7212243 2020. Evaluation of potential therapies for COVID-19 global pandemic.
C7212249 2020. Demand for potentially hazardous COVID-19 treatments.
C7212241 2020. Hydroxychloroquine-associated QT interval prolongation.
C7221540 2020. Current evidence for directed and supportive investigational therapies against COVID-19.
C7174165 ?. COVID-19 ACE -inhibitors and angiotensin receptor blockers-: The need to differentiate between early infection and acute lung injury.
C7227203 ?. Translation: Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7): National Health Commission National Administration of Traditional Chinese Medicine.
32639711 ?. CNS Penetration Ability: A Critical Factor for Drugs in the Treatment of SARS-CoV-2 Brain Infection.
32665809 ?. Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment.
C7269097 ?. Exploiting Existing Molecular Scaffolds for Long-Term COVID Treatment.
C7315437 2020. Recommender Systems in Antiviral Drug Discovery.
C7301903 ?. The Potential of Antimicrobial Peptides as an Antiviral Therapy against COVID-19.
C7319939 ?. Combating COVID-19 with integrated traditional Chinese and Western medicine in China.
C7278644 ?. Bioactive natural compounds against human coronaviruses: a review and perspective.
C7260574 ?. Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight.
C7251357 ?. Analysis on herbal medicines utilized for treatment of COVID-19.
C7255283 ?. Letter to the editor: Comment on GLP-1-based drugs and COVID-19 treatment.
C7252145 ?. Dose selection of chloroquine phosphate for treatment of COVID-19 based on a physiologically based pharmacokinetic model.
C7252136 ?. Chinese medicine diagnosis and treatment for COVID-2019: Is China ready for implementing a national guideline?
C7235485 ?. Addressing COVID?19 Drug Development with Artificial Intelligence.
C7239013 ?. Extent of Prior Lung Irradiation and Mortality in COVID-19 Patients With a Cancer History.
C7235566 ?. Covert COVID-19: Cone Beam Computed Tomography Lung Changes in an Asymptomatic Patient Receiving Radiation Therapy.
32711735 2020. Reverse genetic systems: Rational design of coronavirus live attenuated vaccines with immune sequelae.
32666027 2020. Pharmaceutical care of chloroquine phosphate in elderly patients with coronavirus pneumonia (COVID?19).
C7342052 ?. The role of Chinese medicine in COVID-19 pneumonia: A systematic review and meta-analysis.
C7332446 ?. Traditional chinese medicine and COVID-19: should emergency practitioners use it?
C7332432 ?. Convalescent plasma for coronavirus disease 2019 in pregnancy: a case report and review.
C7314679 ?. Compassionate use of remdesivir for treatment of severe coronavirus disease 2019 in pregnant women at a United States academic center.
C7308040 ?. Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019.
C7342085 ?. Chloroquine and hydroxychloroquine ototoxicity; potential implications for SARS-CoV-2 treatment. A brief review of the literature.
C7303718 2020. Reply to Jakovac: ?COVID-19 and vitamin D?Is there a link and an opportunity for intervention??.
C7328534 ?. Tocilizumab in a child with acute lymphoblastic leukaemia and COVID-19-related cytokine release syndrome?.
C7343652 2020. The use of dexamethasone in the treatment of COVID-19.
C7314270 2020. Convalescent plasma transfusion a promising therapy for coronavirus diseases 2019 (COVID-19): current updates.
32659292 ?. Immunoglobulin fragment F(ab?)2 against RBD potently neutralizes SARS-CoV-2 in vitro.
32659293 2020. Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection.
32675039 ?. Hydroxychloroquine and Potential Drug Interactions in Older Adults.
C7340065 ?. Propiedades antivirales y antiinflamatorias de ivermectina y su potencial uso en COVID-19.
32660794 ?. Response to: Amantadine Treatment for People with COVID-19.
C7335243 ?. Recent insights for the emerging COVID-19: drug discovery therapeutic options and vaccine development.
32682671 ?. Nutrition management for critically and acutely unwell hospitalised patients with coronavirus disease 2019 (COVID-19) in Australia and New Zealand.
C7342031 2020. Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment.
C7303599 2020. Yidu-toxicity blocking lung decoction ameliorates inflammation in severe pneumonia of SARS-COV-2 patients with Yidu-toxicity blocking lung syndrome by eliminating IL-6 and TNF-a.
C7331567 2020. The SARS-CoV-2 main protease as drug target.
C7346814 ?. Debate on Bacille Calmette-Guérin vaccination against COVID-19: Is it worth performing clinical trials?
C7343650 ?. Molecular targets for COVID-19 drug development: Enlightening Nigerians about the pandemic and future treatment.
C7358153 ?. Artemisia et COVID-19.
C7354262 ?. Vaccinating against COVID-19: The quest for the Grail?
C7354263 ?. Thermal cures and COVID-19. head
C7323647 2020. Coronavirus vaccines.
C7317079 2020. Hydroxychloroquine: QTc prolongation: case report.
C7317072 2020. Methylprednisolone/prednisone: Accelerated viral replication following an off-label treatment: case report.
C7317070 2020. Antibacterials/isavuconazole/voriconazole: Lack of efficacy: case report.
C7318723 2020. Multiklonale Antikörper als Ersatz für Zweitantikörper aus Seren.
C7318721 2020. Rekombinante vollständig humane Antikörper zur Behandlung akuter COVID-19.
C7332229 2020. Azaphenantherene derivatives as inhibitor of SARS CoV-2 Mpro: Synthesis physicochemical quantum chemical and molecular docking analysis.
C7291614 2020. COVID-19 und evidenzbasierte Medizin.
C7291615 2020. Remdesivir wohl wirksam bei COVID-19.
C7291608 2020. Lopinavir-Ritonavir-Kombination nicht wirksam.
C7303435 2020. Azithromycin/hydroxychloroquine: Prolongation of the QT interval: case report.
C7303433 2020. Methylprednisolone: Decrease in T cell count following off label use: case report.
C7323139 2020. Vitamin intervention for cytokine storm in the patients with coronavirus disease 2019.
C7337782 ?. Cholesterol-modifying drugs in COVID-19.

32596616 2020. Extraction, Characterization, and Anticoagulant Activity of a Sulfated Polysaccharide from Bursatella leachii Viscera.
32579890 2020. Targeting drug delivery in the vascular system: Focus on endothelium.
32654004 2020. Comments on: The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality.
32653224 2020. BCG as a game-changer to prevent the infection and severity of COVID-19 pandemic?
32624192 2020. Recent Findings on Cardiovascular Safety With the Use of Chloroquine and Hydroxychloroquine for COVID-19.
32502485 2020. Hydroxychloroquine for Coronavirus: The Urgent Need for a Moratorium on Prescriptions.
32653550 2020. Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?
32606531 2020. Hydroxychloroquine and Myasthenia Gravis-Can One Take This Risk?
32637086 2020. A severe refractory COVID-19 patient responding to convalescent plasma; A case series.
32653425 2020. Does androgen deprivation therapy protect against severe complications from COVID-19?
32653452 2020. Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions.
32607398 2020. The Application of a Reduced Dye Used in Orthopedics as a Novel Treatment against Coronavirus (COVID-19): A Suggested Therapeutic Protocol.
32600868 2020. Glucose-6-Phosphate Dehydrogenase Deficiency: An Actionable Risk Factor for Patients with COVID-19?
32611537 2020. Assessing the application of a pseudovirus system for emerging SARS-CoV-2 and re-emerging avian influenza virus H5 subtypes in vaccine development.
32603888 2020. Clinical implications of nicotine as an antimicrobial agent and immune modulator.
32626733 2020. Effect of Thymoquinone on Acute Kidney Injury Induced by Sepsis in BALB/c Mice.
32443566 2020. Metformin: Sentinel of the Epigenetic Landscapes That Underlie Cell Fate and Identity.
32120929 2020. Antiviral Action of Tryptanthrin Isolated from Strobilanthes cusia Leaf against Human Coronavirus NL63.
32629280 2020. COVID19 inhibitors: A prospective therapeutics.
22446091 2012. Synthesis and antiviral activity of a series of 1'-substituted 4-aza-7,9-dideazaadenosine C-nucleosides.
32297972 2020. Built-in RNA-mediated chaperone (chaperna) for antigen folding tailored to immunized hosts.
30597533 2019. Synthetic biology for bioengineering virus-like particle vaccines.
26212697 2015. Viral vaccines and their manufacturing cell substrates: New trends and designs in modern vaccinology.
20809484 2010. Generating stable Chinese hamster ovary cell clones to produce a truncated SARS-CoV spike protein for vaccine development.
16321039 2005. Bioprocess engineering issues that would be faced in producing a DNA vaccine at up to 100 m3 fermentation scale for an influenza pandemic.
32493296 2020. Network pharmacology to dissect the mechanisms of Yinlai Decoction for pneumonia.
32601089 2020. Food is medicine: actions to integrate food and nutrition into healthcare.
32444705 2020. Hydrogen peroxide mouthwash.
32591697 2020. New video will promote silver diamine fluoride to children.
32591690 2020. Chlorhexidine has an antiviral effect against viruses.
32591675 2020. Virucidal activity.
32591671 2020. Povidone iodine gargle and mouthwash.
32307721 2020. Extensive hard palate hyperpigmentation associated with chloroquine use.
32615072 2020. Ivermectin: potential candidate for the treatment of Covid 19.
32645327 2020. A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS.
32643603 2020. Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment.
32442424 2020. Enhancing the Antiviral Efficacy of RNA-Dependent RNA Polymerase Inhibition by Combination with Modulators of Pyrimidine Metabolism.
32544459 2020. BCG Vaccination in Humans Elicits Trained Immunity via the Hematopoietic Progenitor Compartment.
32402267 2020. Metformin Enhances Autophagy and Normalizes Mitochondrial Function to Alleviate Aging-Associated Inflammation.
32612152 2020. Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19.
32629149 2020. Janus sword actions of chloroquine and hydroxychloroquine against COVID-19.
16511823 2006. Deciphering the biosynthetic codes for the potent anti-SARS-CoV cyclodepsipeptide valinomycin in Streptomyces tsusimaensis ATCC 15141.
23788528 2013. Synergistic inhibitor binding to the papain-like protease of human SARS coronavirus: mechanistic and inhibitor design implications.
32533956 2020. Impact of Small-N Studies During a Pandemic.
32505301 2020. Adjunctive Therapies in ARDS: The Disconnect Between Clinical Trials and Clinical Practice.
32632717 2020. In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking.
32405143 2020. Remdesivir - A giant step, or a tiptoe?
32512231 2020. Tuberculosis sepsis after tocilizumab treatment.
32651020 2020. COVID-19: Regulatory Landscape of Medicinal and Medical Device Products for Human Use.
32613089 2020. Low dose anti-inflammatory radiotherapy for the treatment of pneumonia by covid-19: A proposal for a multi-centric prospective trial.
32402130 2020. What Do We Know About Remdesivir Drug Interactions?
32623357 2020. Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors.
32661494 2020. Computational View toward the Inhibition of SARS-CoV-2 Spike Glycoprotein and the 3CL Protease.
32653043 2020. Administration of umbilical cord mesenchymal stem cells in patients with severe COVID-19 pneumonia.
32653015 2020. Comparison of hydroxychloroquine, lopinavir/ritonavir, and standard of care in critically ill patients with SARS-CoV-2 pneumonia: an opportunistic retrospective analysis.
32426753 2020. Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019.
32637266 2020. Lithium Toxicity in Two Coronavirus Disease 2019 (COVID-19) Patients.
32626630 2020. Serious Adverse Events Associated With Hydroxychloroquine Amidst COVID-19 Pandemic: Case Series and Literature Review.
32637278 2020. Packed Red Blood Cell Transfusion as a Potential Treatment Option in COVID-19 Patients With Hypoxemic Respiratory Failure: A Case Report.
32656044 2020. Pulse Therapy With Corticosteroids and Intravenous Immunoglobulin in the Management of Severe Tocilizumab-Resistant COVID-19: A Report of Three Clinical Cases.
32615514 2020. Docking approaches for modeling multi-molecular assemblies.
32399388 2020. Utilization of Physiologically Based Pharmacokinetic Modeling in Clinical Pharmacology and Therapeutics: an Overview.
32616467 2020. Mesenchymal stem cells in the fight against viruses: Face to face with the invisible enemy.
32616381 2020. A critical evaluation of glucocorticoids in the management of severe COVID-19.
32636055 2020. The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19.
32227604 2020. Repurposing therapeutic agents and herbal medicines to defeat viral nemesis.
32655654 2020. Coronavirus disease 2019 (COVID-19): latest developments in potential treatments.
32636919 2020. Can vitamins and/or supplements provide hope against coronavirus?
32427191 2019. Evaluation of safety, humoral immune response and faecal shedding in horses inoculated with a modified-live bovine coronavirus vaccination.
32619884 2020. Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?
32506216 2020. Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase(R).
32653152 2020. Waste in COVID-19 clinical trials conducted in western Europe.
32651040 2020. Linking hydroxychloroquine to hemolysis in a 'suspected' glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection - a critical appraisal.
32652408 2020. Natural and nature-inspired stilbenoids as antiviral agents.
32616594 2020. Cyclophilin Inhibitors Restrict Middle East Respiratory Syndrome Coronavirus Via Interferon lambda In Vitro And In Mice.
32591664 2020. Are hydroxychloroquine and chloroquine effective in the treatment of SARS-COV-2 (COVID-19)?
32587388 2020. Prevalence of hydroxychloroquine retinopathy using 2018 Royal College of Ophthalmologists diagnostic criteria.
32427967 2020. Hydroxychloroquine hitting the headlines-retinal considerations.
32653511 2020. Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19.
32655584 2020. Nanobodies: Prospects of Expanding the Gamut of Neutralizing Antibodies Against the Novel Coronavirus, SARS-CoV-2.
32655583 2020. Vitamin D Supplementation: A Potential Approach for Coronavirus/COVID-19 Therapeutics?
32655582 2020. Targeting the NLRP3 Inflammasome in Severe COVID-19.
32655581 2020. Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies.
32655578 2020. Three Decades of Interferon-beta in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection?
32655577 2020. Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients.
32636851 2020. Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19).
32612616 2020. Potential Treatments for COVID-19 Related Cytokine Storm - Beyond Corticosteroids.
32612613 2020. Activation of TLR7 and Innate Immunity as an Efficient Method Against COVID-19 Pandemic: Imiquimod as a Potential Therapy.
32582186 2020. Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs.
32174911 2020. Quantitative Proteomic Analysis Reveals Antiviral and Anti-inflammatory Effects of Puerarin in Piglets Infected With Porcine Epidemic Diarrhea Virus.
32651936 2020. The role played by traditional Chinese medicine in preventing and treating COVID-19 in China.
32655532 2020. Biocides and Novel Antimicrobial Agents for the Mitigation of Coronaviruses.
32636755 2020. Potential Benefits of Tryptophan Metabolism to the Efficacy of Tocilizumab in COVID-19.
32636754 2020. A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic.
32390855 2020. Traditional Chinese Medicine and Gut Microbiome: Their Respective and Concert Effects on Healthcare.
32636763 2020. The Potential Beneficial Effect of EPA and DHA Supplementation Managing Cytokine Storm in Coronavirus Disease.
32636762 2020. Activation of Ang-(1-7)/Mas Receptor Is a Possible Strategy to Treat Coronavirus (SARS-CoV-2) Infection.
32352313 2020. Incipient need of targeting airway remodeling using advanced drug delivery in chronic respiratory diseases.
32647807 2020. The Emerging Role of Convalescent Plasma in the Treatment of COVID-19.
32606420 2020. The value of targeting recombination as a strategy against coronavirus diseases.

32725866 2020. A Pharmacokinetics-Informed Approach to Navigating Hydroxychloroquine Shortages in Patients With Rheumatic Disease During the COVID-19 Pandemic.
32743211 2020. Prediction of Small Molecule Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus-2 RNA-dependent RNA Polymerase.
32737471 2020. Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients.
32656827 2020. Letter: ACE2, Rho kinase inhibition and the potential role of vitamin D against COVID-19.
32672049 2020. Reply to Jakovac: COVID-19, vitamin D, and type I interferon.
32730105 2020. Update Alert 2: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians.
32732245 2020. Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome.
32722164 2020. Flavonoids Activation of the Transcription Factor Nrf2 as a Hypothesis Approach for the Prevention and Modulation of SARS-CoV-2 Infection Severity.
32739404 2020. The chemokine receptor antagonist cenicriviroc inhibits the replication of SARS-CoV-2 in vitro.
32740801 2020. Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19.
32741139 2020. Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-analysis.
32739342 2020. COVID-19: An overview of the current pharmacological interventions, vaccines, and clinical trials.
32743022 2020. Targeting the cholinergic anti-inflammatory pathway with vagus nerve stimulation in patients with Covid-19?
32731331 2020. The Antiviral Properties of Cyclosporine. Focus on Coronavirus, Hepatitis C Virus, Influenza Virus, and Human Immunodeficiency Virus Infections.
32736237 2020. Clinical efficacy of glucocorticoid on the treatment of patients with COVID-19 pneumonia: A single-center experience.
32718376 2020. Clozapine and COVID-19.
32731913 2020. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment.
32732190 2020. Drug treatments for covid-19: living systematic review and network meta-analysis.
32734502 2020. Anakinra for the Treatment of COVID-19-Associated Pericarditis: A Case Report.
32678443 2020. Cardiovascular diseases, lipid-lowering therapies and European registries in the COVID-19 pandemic.
32745670 2020. New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19?
32728202 2020. Immune monitoring of interleukin-7 compassionate use in a critically ill COVID-19 patient.
32721383 2020. Computationally Optimized SARS-CoV-2 MHC Class I and II Vaccine Formulations Predicted to Target Human Haplotype Distributions.
32735799 2020. Roles of flavonoids against coronavirus infection.
32740825 2020. In Silico Screening of Potential Spike Glycoprotein Inhibitors of SARS-CoV-2 with Drug Repurposing Strategy.
32728975 2020. Physical exercise as a tool to help the immune system against COVID-19: an integrative review of the current literature.
32721580 2020. Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019.
32735655 2020. The Multidimensional Challenge of Treating COVID-19: Remdesivir is a Foot in the Door.
32725382 2020. Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents.
32728438 2020. Safety and potential efficacy of cyclooxygenase-2 inhibitors in coronavirus disease 2019.
32738628 2020. In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19.
32718345 2020. Inhibiting IL-6 in COVID-19: we are not sure.
32734518 2020. Classification of the present pharmaceutical agents based on the possible effective mechanism on the COVID-19 infection.
32740972 2020. Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes.
32735689 2020. Dihydroorotate dehydrogenase inhibitors in SARS-CoV-2 infection.
32730844 2020. Structure-based drug repositioning over the human TMPRSS2 protease domain: search for chemical probes able to repress SARS-CoV-2 Spike protein cleavages.
32725454 2020. Liver injury in remdesivir-treated COVID-19 patients.
32681497 2020. COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy.
32740858 2020. The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse.
32745811 2020. Genetic comparison among various coronavirus strains for the identification of potential vaccine targets of SARS-CoV2.
32739476 2020. Repurposing of host-based therapeutic agents for the treatment of coronavirus disease 2019 (COVID-19): a link between antiviral and anticancer mechanisms?
32738307 2020. Recommendations for use of a hydroxychloroquine loading dose in patients with COVID-19.
32738306 2020. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
32738305 2020. Lactoferrin as potential preventative and adjunct treatment for COVID-19.
32745548 2020. Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening.
32745629 2020. A sound approach: Hydroxychloroquine reduces mortality in severe COVID-19.
32738492 2020. Problems with the analysis in "Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19".
32738491 2020. Effectiveness of hydroxychloroquine in COVID-19 disease: A done and dusted deal?
32738483 2020. Clarifying the record on hydroxychloroquine for the treatment of patients hospitalized with COVID-19.
32726724 2020. Appropriate use of Tocilizumab in COVID-19 Infection.
32721534 2020. Adsorptive granulocyte and monocyte apheresis: A potentially relevant therapeutic option for COVID-19.
32721528 2020. Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge.
32731361 2020. Computational Studies of SARS-CoV-2 3CLpro: Insights from MD Simulations.
32727145 2020. Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19?
32718020 2020. Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials.
32727996 2020. Acute Gouty Arthritis During Favipiravir Treatment for Coronavirus Disease 2019: A Case Report.
32727845 2020. Identification of an anti-SARS-CoV-2 receptor binding domain directed human monoclonal antibody from a naive semi-synthetic library.
32741313 2020. Identification of potential drug candidates to combat COVID-19: a structural study using the main protease (mpro) of SARS-CoV-2.
32727069 2020. A Cell-Based Reporter Assay for Screening Inhibitors of MERS Coronavirus RNA-Dependent RNA Polymerase Activity.
32726951 2020. Efficacy of Corticosteroids in Patients with SARS, MERS and COVID-19: A Systematic Review and Meta-Analysis.
32741525 2020. Attenuating hyperinflammation in COVID-19: A change in paradigm?
32726446 2020. Plasmodium falciparum infection may protect a population from SARS-CoV-2 infection.
32726430 2020. Virucidal efficacy of different oral rinses against SARS-CoV-2.
32745348 2020. Use of the IL-6R Antagonist Tocilizumab in Hospitalized COVID-19 Patients.
32744399 2020. Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID-19: a retrospective cohort study.
32745925 2020. Polyacylated anthocyanins constructively network with catalytic dyad residues of 3CL(pro) of 2019-nCoV than monomeric anthocyanins: A structural-relationship activity study with 10 anthocyanins using in-silico approaches.
32739642 2020. Prioritizing potential ACE2 inhibitors in the COVID-19 pandemic: Insights from a molecular mechanics-assisted structure-based virtual screening experiment.
32676670 2020. Considerations and Future Directions for Conducting Clinical Research With Pediatric Populations During the COVID-19 Pandemic.
32729620 2020. Mesenchymal Stem Cells in COVID-19: A Journey from Bench to Bedside.
32726783 2020. JAK/STAT Pathway Inhibition May Be a Promising Therapy for COVID-19-Related Hyperinflammation in Hematologic Patients.
32726479 2020. Bacillus Calmette-Guerin vaccination and socioeconomic variables vs COVID-19 global features: Clearing up a controversial issue.
32729180 2020. Molecular Insights into Small Molecule Drug Discovery for SARS-CoV-2.
32735169 2020. Deploying Randomized Controlled Trials during the COVID-19 Pandemic: Reason and Bayesian Designs.
32737112 2020. Targeting IL-6 in COVID-19. Response to: 'Rational use of tocilizumab in COVID-19' by Jain and Sharma.
32737108 2020. Response to: 'Rational use of tocilizumab in COVID-19' by Jain and Sharma.
32737107 2020. More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia.
32737106 2020. Rational use of tocilizumab in COVID-19.
32737105 2020. Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: 'More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia' by Ferraccioli.
32744511 2020. Evaluation of drugs for potential repurposing against COVID-19 using a tier-based scoring system.
32725790 2020. Synergy between cytokines and risk factors in the cytokine storm of Covid-19: protection from the chronic use of cytokine inhibitors?
32735127 2020. Point-of-care and utility in clinical trials: making quicker decisions to transform patient care and drug development.
32732352 2020. Remdesivir for severe covid-19: a clinical practice guideline.
32732277 2020. Covid-19: Remdesivir probably reduces recovery time, but evidence is uncertain, panel finds.
32719054 2020. Sacubitril, valsartan and SARS-CoV-2.
32723436 2020. COVID-19: disCOVering the role of complement system.
32745524 2020. Critical COVID-19 disease, homeostasis, and the "surprise" of effective glucocorticoid therapy.
32723229 2020. Could Targeting HMGB1 be useful for the Clinical Management of COVID-19 Infection?
32729428 2020. The Promise of Mesenchymal stem cells therapy for acute Respiratory Distress Syndrome Caused by COVID-19.
32729640 2020. Probing 3CL protease: Rationally designed chemical moieties for COVID-19.
32739174 2020. Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection.
32744917 2020. Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects.
32729363 2020. Development and progress of clinical trials of Coronavirus Disease 2019 antiviral drugs.
32734777 2020. Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis.
32745502 2020. Probing antiviral drugs against SARS-CoV-2 through virus-drug association prediction based on the KATZ method.
32742008 2020. Repurposed Drugs Against COVID-19: Safety Concerns and Stockout.
32718300 2020. In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases.
32744166 2020. Is vitamin C an effective agent for the prevention of COVID-19 and treatment of severe infection in the ICU?
32744052 2020. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
32734828 2020. Tackling COVID-19: identification of potential main protease inhibitors via structural analysis, virtual screening, molecular docking and MM-PBSA calculations.
32729392 2020. Antiviral potential of some novel structural analogs of standard drugs repurposed for the treatment of COVID-19.
32741322 2020. Identification of promising drug candidates against NSP16 of SARS-CoV-2 through computational drug repurposing study.
32741312 2020. Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic.
32741259 2020. Identification of potential anti-TMPRSS2 natural products through homology modelling, virtual screening and molecular dynamics simulation studies.
32740262 2020. Understanding COVID-19 Vaccines and Their Development.
32740441 2020. Low hospitalization rate without severe arrhythmias: a prospective survey on 350 patients early home treated with hydroxychloroquine during COVID-19 pandemia.
32734670 2020. Characteristics of Clinical Trials relating to COVID-19 registered at ClinicalTrials.gov.
32729947 2020. Could an acute respiratory distress syndrome in COVID-19 infected patients be calmed down simply by iron withdrawal from lung tissues?
32730617 2020. Characteristics and Strength of Evidence of COVID-19 Studies Registered on ClinicalTrials.gov.
32744622 2020. The Uncertain Role of Corticosteroids in the Treatment of COVID-19.
32744600 2020. The Uncertain Role of Corticosteroids in the Treatment of COVID-19-Reply.
32744591 2020. The Uncertain Role of Corticosteroids in the Treatment of COVID-19.
32722777 2020. Benefits and Safety of Nasal Saline Irrigations in a Pandemic-Washing COVID-19 Away.

32761294 2020. The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation.
32765941 2020. Bioactive Lipids as Mediators of the Beneficial Action(s) of Mesenchymal Stem Cells in COVID-19.
32765939 2020. COVID-19 and Senotherapeutics: Any Role for the Naturally-occurring Dipeptide Carnosine?
32765938 2020. Potential Using of Fat-derived Stromal Cells in the Treatment of Active Disease, and also, in Both Pre- and Post-Periods in COVID-19.
32767400 2020. Dupilumab, severe asthma airway responses, and SARS-CoV-2 serology.
32762135 2020. Cabbage and fermented vegetables: from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19.
32774998 2020. Principles and treatment strategies for the use of Chinese herbal medicine in patients at different stages of coronavirus infection.
32616373 2020. The influence of corticosteroid on patients with COVID-19 infection: A meta-analysis.
32744592 2020. Searching for COVID-19 treatments: First, do no harm.
32761732 2020. The COVID-19 liquid gold rush: Critical perspectives of human milk and SARS-CoV-2 infection.
32755302 2020. MAY PHYTOTHERAPY WITH POLYPHENOLS SERVE AS A POWERFUL APPROACH FOR THE PREVENTION AND THERAPY TOOL OF NOVEL CORONAVIRUS DISEASE 2019 (COVID-19)?
32778354 2020. Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention.
32541234 2020. The Impact of COVID-19 on Clinical Trials.
32763313 2020. Remdesivir triphosphate can efficiently inhibit the RNA-dependent RNA polymerase from various flaviviruses.
32723524 2020. Response to: Amantadine, COVID-19 and Parkinsonism.
32779737 2020. The absorbing filter Oxiris in severe COVID-19 patients: A case series.
32674226 2020. Covid-19 and dietary socioecology: Risk minimisation.
32773989 2020. Repurposing of known anti-virals as potential inhibitors for SARS-CoV-2 main protease using molecular docking analysis.
32754003 2020. Potential Drugs and Remedies for the Treatment of COVID-19: a Critical Review.
32763818 2020. Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19.
32768882 2020. Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies.
32764129 2020. Patient-centric research in the time of COVID-19: conducting ethical COVID-19 research in Africa.
32779815 2020. Pharmacokinetic considerations on the repurposing of ivermectin for treatment of COVID-19.
32776354 2020. The hidden role of NLRP3 inflammasome in obesity-related COVID-19 exacerbations: Lessons for drug repurposing.
32778225 2020. Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2.
32767687 2020. Stem cell therapy for COVID-19: Possibilities and challenges.
32772307 2020. Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?
32779609 2020. Glucocorticoid-Induced Bacterial Endocarditis in COVID-19 Pneumonia- Something to Be Concerned About?
32771488 2020. Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19.
32772069 2020. Clinical Outcomes Associated with Methylprednisolone in Mechanically Ventilated Patients with COVID-19.
32770240 2020. AVIFAVIR for Treatment of Patients with Moderate COVID-19: Interim Results of a Phase II/III Multicenter Randomized Clinical Trial.
32780788 2020. Gut microbiota and COVID-19: A superfluous diagnostic biomarker or therapeutic target?
32767755 2020. Physiologically-Based Pharmacokinetic Modeling to Predict the Clinical Efficacy of the Coadministration of Lopinavir and Ritonavir against SARS-CoV-2.
32771054 2020. Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study.
32766569 2020. Treatment for Severe Coronavirus Disease 2019 With the Seraph-100 Microbind Affinity Blood Filter.
32779824 2020. Volatile molecules for COVID-19: A possible pharmacological strategy?
32770567 2020. Epigallocatechin gallate and theaflavin gallate interaction in SARS-CoV-2 spike-protein central channel with reference to the hydroxychloroquine interaction: Bioinformatics and molecular docking study.
32761647 2020. Snake venom-derived bradykinin-potentiating peptides: A promising therapy for COVID-19?
32777537 2020. Global clinical trial mobilization for COVID-19: higher, faster, stronger.
32753375 2020. BET 1: The role of remdesivir in COVID-19 infection.
32730568 2020. Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes.
32780229 2020. Safety of hydroxychloroquine in COVID-19 and other diseases: a systematic review and meta-analysis of 53 randomized trials.
32780273 2020. Pharmacokinetic Basis of the Hydroxychloroquine Response in COVID-19: Implications for Therapy and Prevention.
32725286 2020. Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19?
32735546 2020. The Anatomy of the SARS-CoV-2 Biomedical Literature: Introducing the CovidX Network Algorithm for Drug Repurposing Recommendation.
32723801 2020. Drug discovery strategies for SARS-CoV-2.
32735992 2020. Design of an engineered ACE2 as a novel therapeutics against COVID-19.
32738928 2020. Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?
32738360 2020. Computational guided drug repurposing for targeting 2'-O-ribose methyltransferase of SARS-CoV-2.
32727107 2020. Rapid and Impressive Response to a Combined Treatment with Single-Dose Tocilizumab and NIV in a Patient with COVID-19 Pneumonia/ARDS.
32722020 2020. Low Albumin Levels Are Associated with Poorer Outcomes in a Case Series of COVID-19 Patients in Spain: A Retrospective Cohort Study.
32737681 2020. Identification of potential Mpro inhibitors for the treatment of COVID-19 by using systematic virtual screening approach.
32722908 2020. Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.
32715661 2020. Hypothesis: Pentoxifylline is a potential cytokine modulator therapeutic in COVID-19 patients.
32726304 2020. Developing a low-cost and accessible COVID-19 vaccine for global health.
32735326 2020. Potential role of hypovitaminosis D and Vitamin D supplementation during COVID-19 pandemic.
32703908 2020. Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody.
32740890 2020. Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients.
32739472 2020. Apparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19.
32718128 2020. Perspectives for the immune plasma treatment of COVID-19.
32731461 2020. Vaccine Design from the Ensemble of Surface Glycoprotein Epitopes of SARS-CoV-2: An Immunoinformatics Approach.
32717854 2020. Immunogenic SARS-CoV-2 Epitopes: In Silico Study Towards Better Understanding of COVID-19 Disease-Paving the Way for Vaccine Development.
32717346 2020. Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy.
32722574 2020. In Silico Insights into the SARS CoV-2 Main Protease Suggest NADH Endogenous Defences in the Control of the Pandemic Coronavirus Infection.
32734479 2020. Partially ionized medical oxygen as a supplementary treatment for COVID-19.
32668969 2020. Potential Targets for Treatment of Coronavirus Disease 2019 (COVID-19): A Review of Qing-Fei-Pai-Du-Tang and Its Major Herbs.
32631576 2020. Carvedilol and COVID-19: A Potential Role in Reducing Infectivity and Infection Severity of SARS-CoV-2.
32622469 2020. Is Inhaled Furosemide a Potential Therapeutic for COVID-19?
32750259 2020. COVID-19: Clean up on IL-6.
32749854 2020. Reply to: Does Vaping Increase Susceptibility to COVID-19?
32753413 2020. To immunosuppress: whom, when and how? That is the question with COVID-19.
32719045 2020. Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study.
32737111 2020. COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine.
32737109 2020. Response to: 'COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine' by Teh et al.
32732244 2020. Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience.
32732243 2020. Comment on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M et al.
32769154 2020. Correspondence on 'Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist' by Graef et al.
32769153 2020. Mild COVID-19 in ANCA-associated vasculitis treated with rituximab.
32769149 2020. Response to: 'Correspondence on 'Festina lente: hydroxychloroquine, COVID-19and the role of the rheumatologist' by Graef et al' by Lo et al.
32759263 2020. Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis.
32759257 2020. Response to: 'Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis' by Singer et al.
32759267 2020. Atazanavir, alone or in combination with ritonavir, inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production.
32701630 2020. Treatment of Cytokine Storm in COVID-19 Patients with Immunomodulatory Therapy.
32740072 2020. Re: Chloroquine (CQ) and Hydroxychloroquine (HQ) Retinal Toxicity Consideration in the Treatment of the Coronavirus Disease 2019 (COVID-19).
32740071 2020. A Word of Caution in the Use of Hydroxychloroquine in the Elderly COVID-19 Population.
32740070 2020. Chloroquine, Hydroxychloroquine, Retinal Toxicity, and COVID-19.
32761219 2020. Convalescent plasma to treat COVID-19.
32759299 2020. Covid-19: Where are we on immunity and vaccines?
32758306 2020. Selenium and viral infection: are there lessons for COVID-19?
32769401 2020. Chloroquine or Hydroxychloroquine for Management of Coronavirus Disease 2019: Friend or Foe?
32773440 2020. A Review of Remdesivir for COVID-19: Data to Date.
32756614 2020. Discovery of sandwich type COVID-19 nucleocapsid protein DNA aptamers.
32755466 2020. Human Cardiac Mesenchymal Stem Cells Remodel in Disease and Can Regulate Arrhythmia Substrates.
32748740 2020. Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking Screening.
32767929 2020. Theoretical Study of the Molecular Mechanism of Maxingyigan Decoction Against COVID-19: Network Pharmacology-based Strategy.
32769050 2020. Repurposing approved drugs as potential inhibitors of 3CL-protease of SARS-CoV-2: Virtual screening and structure based drug design.
32693756 2020. Current Trends and Future Approaches in Small-Molecule Therapeutics for COVID-19.
32767920 2020. The Plausible role of Indian Traditional Medicine in combating Corona Virus (SARS-CoV 2): a mini-review.
32758037 2020. Antiviral drugs and plasma therapy used for Covid-19 treatment: a nationwide Turkish algorithm.
32742146 Summ. Impact of COVID-19 on Clinical Research and Inclusion of Diverse Populations.
32742147 2020. Applying Community-Partnered Participatory Research Approaches to Develop COVID-19 Solutions.
32734625 2020. BCG vaccination early in life does not improve COVID-19 outcome of elderly populations, based on nationally reported data.
32722864 2020. In silico Drug Repurposing for COVID-19: Targeting SARS-CoV-2 Proteins through Docking and Consensus Ranking.
32726549 2020. Audio Interview: New SARS-CoV-2 Vaccine Results, with Peter Piot.
32704139 2020. Next-generation vaccine platforms for COVID-19.
32704138 2020. COVID-19 therapies and vaccine landscape.
32737466 2020. Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient.
32731258 2020. ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.
32731257 2020. Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.
32726802 2020. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.
32726800 2020. Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis.
32710694 2020. Potential limitations of plasmapheresis in treatment of COVID-19 patients: How to overcome them?

32755604 2020. Teaching Old Drugs New Tricks: Statins for COVID-19?
32755598 2020. A Carbohydrate-Binding Protein from the Edible Lablab Beans Effectively Blocks the Infections of Influenza Viruses and SARS-CoV-2.
32759966 2020. A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2.
32761452 2020. Sex differences in COVID-19 mortality: opportunity to develop HSP27 (HSPB1) immunotherapy to treat hyper-inflammation?
32761336 2020. Role of Complementary and Alternative Medicine in Prevention and Treatment of COVID-19: An Overhyped Hope.
32754224 2020. Potential mechanism prediction of Cold-Damp Plague Formula against COVID-19 via network pharmacology analysis and molecular docking.
32759176 2020. Convalescent plasma for COVID-19.
32671831 2020. COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases.
32702224 2020. Clozapine in the Time of COVID-19.
32736332 2020. Determination of an optimal control strategy for vaccine administration in COVID-19 pandemic treatment.
32654163 2020. First case of DRESS syndrome caused by hydroxychloroquine with a positive patch test.
32753056 2020. Plasma exchange in critically ill COVID-19 patients.
32754408 2020. The Potential Vaccine Component for COVID-19: A Comprehensive Review of Global Vaccine Development Efforts.
32754388 2020. Potential Treatment Options for COVID-19: A Comprehensive Review of Global Pharmacological Development Efforts.
32699671 2020. Debunking Cannabidiol as a Treatment for COVID-19: Time for the FDA to Adopt a Focused Deterrence Model?
32685300 2020. The Role of Interleukin-6 Inhibitors in the Treatment of COVID-19 Infections: A Case Series.
32750451 2020. Metformin and COVID-19: From cellular mechanisms to reduced mortality.
32771797 2020. Potential treatment methods targeting 2019-nCoV infection.
32777212 2020. What to expect from different drugs used in the treatment of COVID-19: A study on applications and in vivo and in vitro results.
32768505 2020. COVID-19: A review of the proposed pharmacological treatments.
32768503 2020. In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2.
32763302 2020. Coronavirus diseases 2019: Current biological situation and potential therapeutic perspective.
32763298 2020. Molecular effects and retinopathy induced by hydroxychloroquine during SARS-CoV-2 therapy: Role of CYP450 isoforms and epigenetic modulations.
32764115 2020. SARS-CoV2 disrupts clinical research - the role of a rare disease-specific trial network.
32779213 2020. COVID-19 and Vitamin D: A lesson from the skin.
32762581 2020. Immunotherapy for SARS-CoV-2: potential opportunities.
32780893 2020. Rationale for the use of N-acetylcysteine in both prevention and adjuvant therapy of COVID-19.
32777281 2020. What underlies the benefit of famotidine formulations used during COVID-19?
32771622 2020. Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approach.
32767854 2020. Letter to the Editors: Statins and COVID-19: Efficacy Still to Be Proven.
32780299 2020. Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective.
32774508 2020. Chloroquine and COVID-19: Should We Care about Ototoxicity?
32777263 2020. Effects of Hydroxychloroquine on Covid-19 in Intensive Care Unit Patients: Preliminary Results.
32767379 2020. Biologic drugs during COVID-19 outbreak.
32771630 2020. Comment on Arshad et al: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19.
32768697 2020. Vitamin D3 and K2 and their potential contribution to reducing the COVID-19 mortality rate.
32768701 2020. Low-Dose Subcutaneous Tocilizumab to Prevent Disease Progression in Patients with Moderate COVID-19 Pneumonia and Hyperinflammation.
32768698 2020. Hydroxychloroquine in COVID-19: taking care of statistic to take care of patients.
32768694 2020. Re: Arshad S, Kilgore P, Chaudhry ZS et al. Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19. Int J Infect Dis: 2020. Epub 2020 Jul 1 http://doi.org/10.1016/j.ijid.2020.06.099.
32768693 2020. Early Identification of COVID-19 Cytokine Storm and Treatment with Anakinra or Tocilizumab.
32766679 2020. Comment on: Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.
32750131 2020. Drug interactions: a review of the unseen danger of experimental COVID-19 therapies.
32770858 2020. Updated information on new coronavirus disease 2019 occurrence, drugs, and prediction of a potential receptor.
32779770 2020. QTc prolongation during antiviral therapy in two COVID-19 patients.
32779201 2020. Immunomodulatory Therapeutic Proteins in COVID-19: Current Clinical Development and Clinical Pharmacology Considerations.
32773258 2020. Therapeutic plasma exchange resolving COVID-19 related ARDS.
32777441 2020. Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-COV-2 infection?
32763357 2020. Hydroxychloroquine use in Hospitalized Patients with COVID-19: An observational matched cohort study.
32763262 2020. The proper use of corticosteroids for 2019-nCov pneumonia: Towards promising results?
32777038 2020. Convalescent Plasma Therapy on Patients with Severe or Life-Threatening COVID-19: A Metadata Analysis.
32773212 2020. Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review.
32762368 2020. Prolonged QT Interval in a Patient With Coronavirus Disease-2019: Beyond Hydroxychloroquine and Azithromycin.
32779755 2020. Hydroxychloroquine treatment in COVID-19: a descriptive observational analysis of 30 cases from a single center in Wuhan, China.
32767684 2020. Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells.
32749708 2020. Can aldosterone increase interleukin-6 levels in Covid-19 pneumonia?
32749702 2020. Targeting human TLRs to combat COVID-19: A solution?
32776550 2020. Clinical trials of inhaled beclomethasone and mometasone for COVID-19 should be conducted.
32776534 2020. Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: a retrospective cohort study.
32735768 2020. Anti-Inflammatory Properties of Drugs Used to Control COVID-19 and their Effects on the Renin-Angiotensin System and Angiotensin-Converting Enzyme-2.
32770854 2020. Clinical trial to test the efficacy of melatonin in COVID-19.
32765615 2020. Glucocorticoids in COVID19; a friend not foe.
32748578 2020. Interferon-alpha2b spray inhalation did not shorten virus shedding time of SARS-CoV-2 in hospitalized patients: a preliminary matched case-control study.
32776022 2020. Structural Basis for Designing Multiepitope Vaccines Against COVID-19 Infection: In Silico Vaccine Design and Validation.
32777300 2020. Anti-HCV and anti-malaria agent, potential candidates to repurpose for coronavirus infection: Virtual screening, molecular docking, and molecular dynamics simulation study.
32763660 2020. Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content.
32768893 2020. The possible immunoregulatory and anti-inflammatory effects of selective serotonin reuptake inhibitors in coronavirus disease patients.
32755992 2020. MECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID-19.
32633332 2020. The complement inhibitors in COVID-19: future expectations.
32744716 2020. SARS-CoV-2 vs. SARS-CoV-1 management: antibiotics and inflammasome modulators potential.
32744711 2020. Molecular modelling of the antiviral action of Resveratrol derivatives against the activity of two novel SARS CoV-2 and 2019-nCoV receptors.
32767353 2020. Morning vs. evening administration of antiviral therapy in COVID-19 patients. A preliminary retrospective study in Ferrara, Italy.
32767349 2020. Corticosteroid therapy for patients with severe novel Coronavirus disease 2019.
32767348 2020. Inhibitory effects of Vitamin D on inflammation and IL-6 release. A further support for COVID-19 management?
32767316 2020. Hydroxychloroquine (HCQ) use in G6PD deficient COVID-19 patients and the risk of Acute Hemeolytic Anaemia (AHA).
32752970 2020. The trade-off dilemma in pharmacotherapy of COVID-19: systematic review, meta-analysis, and implications.
32746653 2020. Medication therapy strategies for the coronavirus disease 2019 (COVID-19): recent progress and challenges.
32762516 2020. Are BCG-induced non-specific effects adequate to provide protection against COVID-19?
32773415 2020. Hydroxychloroquine for chemoprophylaxis in COVID-19: A case of motivated perception?
32773410 2020. Hydroxychloroquine prophylaxis for SARS-CoV-2 infection among healthcare workers.
32644027 2020. Tocilizumab for COVID-19: a real 'miracle drug'?
32696730 2020. Newly Emergent 2019-nCoV and New Uses of an Old Medicine, Doxycycline; A Hypothesis.
32758675 2020. Immunoinformatic construction of an adenovirus-based modular vaccine platform and its application in the design of a SARS-CoV-2 vaccine.
32729823 2020. Drug evaluation and pharmaceutical care in a critically ill COVID-19 patient.
32718410 2020. Bacille Calmette-Guerin (BCG) vaccine and the COVID-19 pandemic: responsible stewardship is needed.
32740371 2020. A retrospective evaluation on the efficacy of Lopinavir/ritonavir and chloroquine to treat non-severe COVID-19 patients.
32735036 2020. COVID-19 in Nursing Homes: Calming the Perfect Storm.
32610879 2020. Hydroxychloroquine for COVID-19: What is our Current State of Knowledge?
32610873 2020. Characteristics, Treatment Outcomes and Role of Hydroxychloroquine among 522 COVID-19 hospitalized patients in Jaipur City: An Epidemio-Clinical Study.
32738852 2020. Hydroxychloroquin for COVID-19 Why was so much hype?
32762537 2020. In silico virtual screening, characterization, docking and molecular dynamics studies of crucial SARS-CoV-2 proteins.
32762511 2020. In silico investigation of phytoconstituents from Indian medicinal herb 'Tinospora cordifolia (giloy)' against SARS-CoV-2 (COVID-19) by molecular dynamics approach.
32762411 2020. Identification of polyphenols from Broussonetia papyrifera as SARS CoV-2 main protease inhibitors using in silico docking and molecular dynamics simulation approaches.
32752951 2020. Molecular docking, molecular dynamics simulations and reactivity, studies on approved drugs library targeting ACE2 and SARS-CoV-2 binding with ACE2.
32752947 2020. Predictive modeling by deep learning, virtual screening and molecular dynamics study of natural compounds against SARS-CoV-2 main protease.
32752944 2020. Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2.
32752938 2020. In silico identification of widely used and well-tolerated drugs as potential SARS-CoV-2 3C-like protease and viral RNA-dependent RNA polymerase inhibitors for direct use in clinical trials.
32772895 2020. Structural insight to hydroxychloroquine-3C-like proteinase complexation from SARS-CoV-2: inhibitor modelling study through molecular docking and MD-simulation study.
32772892 2020. In silico designing of multi-epitope vaccine construct against human coronavirus infections.
32723468 2020. Convalescent Plasma: Promise for COVID-19 Pandemic.
32723461 2020. Chloroquine and Hydroxychloroquine in COVID-19: Challenges and the Need for Caution in Low-Resource Settings.
32763058 2020. Therapeutic plasma exchange in adult critically ill patients with life-threatening SARS-CoV-2 disease: A pilot study.
32746637 2020. Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro.
32769686 2020. Association between hypertension and pneumonia caused by SARS-CoV-2 in Mexican population.
32711596 2020. Interactions Between Remdesivir, Ribavirin, Favipiravir, Galidesivir, Hydroxychloroquine and Chloroquine with Fragment Molecular of the COVID-19 Main Protease with Inhibitor N3 Complex (PDB ID:6LU7) Using Molecular Docking.
32692185 2020. Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19.
32761166 2020. COVID-19 and Dexamethasone: A Potential Strategy to Avoid Steroid-Related Strongyloides Hyperinfection.
32720611 2020. [Use of Statins, Anticoagulants, Antiaggregants and Antiarrhythmic Drugs in Patients With COVID-19. The Agreed Experts' Position of Russian Society of Cardiology, Eurasian Association of Therapists, National Society on Atherothrombosis, Societies of Experts in Urgent Cardiology, Eurasian Arrhythmology Association].
32747135 2020. Should estrogen be used in the co-treatment of COVID-19 patients? What is the rationale?
32747134 2020. Response to "Should estrogen be used in the co-treatment of COVID-19 patients?"
32679422 2020. Is it possible to use Proton Pump Inhibitors in COVID-19 treatment and prophylaxis?
32759894 2020. Vitamin C for COVID-19: A living systematic review.
32558474 2020. Amplifying RNA Vaccine Development.

32755836 2020. Vaccine development against coronavirus (2003 to present): An overview, recent advances, current scenario, opportunities and challenges.
32749644 2020. ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?
32748035 2020. Nanotechnology-based antiviral therapeutics.
32753842 2020. Plasmapheresis, Anti-ACE2 and Anti-FcgammaRII Monoclonal Antibodies: A Possible Treatment for Severe Cases of COVID-19.
32669523 2020. Traditional Chinese medicine to treat COVID-19: the importance of evidence-based research.
32669519 2020. Re-tasking the use of pre-existing medications and potential therapeutic options for coronavirus disease (COVID-19): systematic review of clinical studies.
32742294 2020. Hydroxychloroquine-induced hyperpigmentation in a 14-year-old female with systemic lupus erythematosus.
32766547 2020. A vaccine for SARS-CoV-2: goals and promises.
32758569 2020. In silico molecular docking analysis for repurposing therapeutics against multiple proteins from SARS-CoV-2.
32750366 2020. An overview of the pathogenic mechanisms involved in severe cases of COVID-19 infection, and the proposal of salicyl-carnosine as a potential drug for its treatment.
32700670 2020. Convalescent plasma treatment for SARS-CoV-2 infection: analysis of the first 436 donors in England, 22 April to 12 May 2020.
32765844 2020. In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19.
32742639 2020. Turning up the heat on COVID-19: heat as a therapeutic intervention.
32704354 2020. Coronavirus disease 2019 drug discovery through molecular docking.
32704352 2020. Recruiting the innate immune system with GM-CSF to fight viral diseases, including West Nile Virus encephalitis and COVID-19.
32752217 2020. Food and COVID-19: Preventive/Co-therapeutic Strategies Explored by Current Clinical Trials and in Silico Studies.
32766256 2020. Preventing Mortality in COVID-19 Patients: Which Cytokine to Target in a Raging Storm?
32766251 2020. The Coronavirus Pandemic (SARS-CoV-2): New Problems Demand New Solutions, the Alternative of Mesenchymal (Stem) Stromal Cells.
32719799 2020. Current Findings Regarding Natural Components With Potential Anti-2019-nCoV Activity.
32760409 2020. Could the Induction of Trained Immunity by beta-Glucan Serve as a Defense Against COVID-19?
32760408 2020. Prevention of Severe Coronavirus Disease 2019 Outcomes by Reducing Low-Grade Inflammation in High-Risk Categories.
32760407 2020. High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects.
32754165 2020. A Hypothesis for the Possible Role of Zinc in the Immunological Pathways Related to COVID-19 Infection.
32754164 2020. The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis.
32754163 2020. Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies.
32754161 2020. Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using in silico Structure-Based Virtual Screening Approach.
32754160 2020. Designing Multi-Epitope Vaccines to Combat Emerging Coronavirus Disease 2019 (COVID-19) by Employing Immuno-Informatics Approach.
32733489 2020. Complement Inhibition in Coronavirus Disease (COVID)-19: A Neglected Therapeutic Option.
32733488 2020. Potential Fast COVID-19 Containment With Trehalose.
32733487 2020. Role of Immune Dysregulation in Increased Mortality Among a Specific Subset of COVID-19 Patients and Immune-Enhancement Strategies for Combatting Through Nutritional Supplements.
32719685 2020. Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies.
32719684 2020. COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning.
32719683 2020. Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment.
32761491 2020. Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19.
32766266 2020. Administration of Immunoglobulins in SARS-CoV-2-Positive Patient Is Associated With Fast Clinical and Radiological Healing: Case Report.
32733907 2020. Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19.
32765482 2020. Therapeutic Strategies Against COVID-19 and Structural Characterization of SARS-CoV-2: A Review.
32754147 2020. Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro.
32765279 2020. Selective Estrogen Receptor Modulators in COVID-19: A Possible Therapeutic Option?
32765274 2020. No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study.
32754036 2020. BCG Against SARS-CoV-2: Second Youth of an Old Age Vaccine?
32733287 2020. Resistance Training in Face of the Coronavirus Outbreak: Time to Think Outside the Box.
32719619 2020. While We Wait for a Vaccine Against SARS-CoV-2, Why Not Think About Available Drugs?
32754571 2020. Novel Coronavirus Pneumonia Treatment With Traditional Chinese Medicine: Response Philosophy in Another Culture.
32754570 2020. Recent Advancements in the Diagnosis, Prevention, and Prospective Drug Therapy of COVID-19.
32733842 2020. Progress in the Research and Development of Anti-COVID-19 Drugs.
32733837 2020. A Perspective on Emerging Therapeutic Interventions for COVID-19.
32719766 2020. Clinical Use of Short-Course and Low-Dose Corticosteroids in Patients With Non-severe COVID-19 During Pneumonia Progression.
32750187 2020. Insights on 3D Structures of Potential Drug-Targeting Proteins of SARS-CoV-2: Application of Cavity Search and Molecular Docking.
32763844 2020. The multiple sclerosis (MS) drugs as a potential treatment of ARDS in COVID-19 patients.
32772313 2020. Anthraquinone Derivatives as an Immune Booster and their Therapeutic Option Against COVID-19.
32778829 2020. After 62 years of regulating immunity, dexamethasone meets COVID-19.
32770341 2020. Use of a Novel Negative-Pressure Tent During Bedside Tracheostomy in COVID-19 Patients.
32667665 2020. Transcriptome-based drug repositioning for coronavirus disease 2019 (COVID-19).
32778962 2020. Repurposing of Kinase Inhibitors for Treatment of COVID-19.
32781283 2020. Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial.
32776317 2020. Low dose radiation therapy for COVID-19 pneumonia: brief review of the evidence.
32773257 2020. Potential influence of Nagella sativa (Black cumin) in reinforcing immune system: A hope to decelerate the COVID-19 pandemic.
32754955 2020. Astaxanthin, COVID-19 and immune response: Focus on oxidative stress, apoptosis and autophagy.
32748969 2020. Evaluation of medicinal herbs as a potential therapeutic option against SARS-CoV-2 targeting its main protease.
32779305 2020. High affinity interaction of Solanum tuberosum and Brassica juncea residue smoke water compounds with proteins involved in coronavirus infection.
32778507 2020. COVID-19 and steroid therapy: Impact on diabetes.
32779326 2020. Drugs against SARS-CoV-2: What do we know about their mode of action?
32773341 2020. Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2?
32779878 2020. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.
32778854 2020. COVID-19: should oral vaccination strategies be given more consideration?
32771272 2020. A Scoping Review of Registered Clinical Trials of Convalescent Plasma for COVID-19 and a Framework for Accelerated Synthesis of Trial Evidence (FAST Evidence).
32770691 2020. Lessons learned from early compassionate use of convalescent plasma on critically ill patients with Covid-19.
32748963 2020. Rapid establishment of a COVID-19 convalescent plasma program in a regional health care delivery network.
32777902 2020. Melatonin, Aging and COVID-19: Could melatonin be beneficial for COVID-19 treatment in elderly?
32773245 2020. Influenza immunization and COVID-19.
32747214 2020. The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines.
32776298 2020. Hydroxychloroquine versus lopinavir/ritonavir in severe COVID-19 patients : Results from a real-life patient cohort.
32767940 2020. Recent Discovery for Inhibitors Targeting in SARS-CoV-2 and Developed anti-NCP.
32760027 2020. Focus shifts to antibody cocktails for COVID-19 cytokine storm.
32770162 2020. Seeds of hope in COVID-19 vaccine preliminary data.
32747742 2020. Dexamethasone nanomedicines for COVID-19.
32760013 2020. Anti-IL-6Rs falter in COVID-19.
32760011 2020. COVID-19 vaccine guidelines.
32756549 2020. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness.
32698192 2020. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike.
32749808 2020. Hydroxychloroquine en chloroquine bij COVID-19.
32639122 2020. COVID-19 Pandemic - Nephrology Experiences.
32732294 2020. Brain death evaluation during the pandemic.
32738510 2020. Parenteral fish oil: An adjuvant pharmacotherapy for coronavirus disease 2019?
32769659 2020. Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19).
32757981 2020. In silico Potential of Approved Antimalarial Drugs for Repurposing Against COVID-19.
32758635 2020. COVID-19: Pharmacology and kinetics of viral clearance.
32758336 2020. Avoiding COVID-19 complications with diabetic patients could be achieved by multi-dose Bacillus Calmette-Guerin vaccine: a case study of beta cells regeneration.
32764148 2020. Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2.
32657706 2020. Benefit v. risk when using chloroquine in patients with severe COVID-19 disease.
32657716 2020. Critical care triaging in the shadow of COVID-19: Ethics considerations.
32747425 2020. 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.
32554572 2020. Pandemic vaccines are about to face the real test.
32631874 2020. The line starts to form for a coronavirus vaccine.
32646976 2020. U.K. megatrial outshines other drug studies.
32753553 2020. Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2.
32739134 2020. Tratamiento farmacologico en tiempos de incertidumbre: uso de la hidroxicloroquina/cloroquina en el tratamiento de COVID-19.
32692266 2020. Potential Repurposed Therapeutics and New Vaccines against COVID-19 and Their Clinical Status.
32773244 2020. Ensuring access and affordability through COVID-19 vaccine research and development investments: A proposal for the options market for vaccines.
32684497 2020. Vaccines based on virus-like nano-particles for use against Middle East Respiratory Syndrome (MERS) coronavirus.
32696759 2020. [Discussion and prospect of infusion of NK cells in the treatment of SARS-CoV-2 infection].
32762168 2020. [Nutritional support for critically ill patients with COVID-19].
32648389 2020. [Exploration of fire needling therapy on coronavirus disease 2019].
32726008 2020. [Analysis of potential role of Chinese classic prescriptions in treatment of COVID-19 based on TCMATCOV platform].
32726006 2020. [Analysis on formula of Mongolian medicine for prevention of COVID-19].
32726005 2020. [Analysis of medication regularity and pharmacodynamic characteristics of traditional Chinese medicine treatment in 444 severe cases of COVID-19].
32726004 2020. [Analysis of traditional Chinese medicine from patent information sharing platform of coronavirus disease 2019 (COVID-19)].
32726003 2020. [Large- scale prospective clinical study on prophylactic intervention of COVID-19 in community population using Huoxiang Zhengqi Oral Liquid and Jinhao Jiere Granules].
32727176 2020. [Analysis of clinical characteristics of 49 cases of COVID-19].
32385989 2020. [Glucocorticoid for coronavirus disease 2019: a dilemma].
32684211 2020. [A comparative study on clinical effects of dexmedetomidine and midazolam on patients with severe coronavirus disease 2019 on non-invasive ventilation].

32733775 2020. Ascorbate as Prophylaxis and Therapy for COVID-19-Update From Shanghai and U.S. Medical Institutions.
32748329 2020. Comment on "Possible prophylactic or preventive role of topical povidone iodine during accidental ocular exposure to 2019-nCoV".
32754651 2020. SARS-CoV-2 RNA Dependent RNA polymerase (RdRp) - A drug repurposing study.
32719218 2020. Safety and efficacy of tocilizumab in the treatment of severe acute respiratory syndrome coronavirus-2 pneumonia: A retrospective cohort study.
32757500 2020. Clinical Experience with Use of Remdesivir in the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: a Case Series.
32757497 2020. Early Hydroxychloroquine Administration for Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Eradication.
32741372 2020. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
32760915 2020. Glucocorticoids save lives in COVID-19 patients.
32760206 2020. Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels.
32676542 2020. Insights into Potential Mechanisms of Injury and Treatment Targets in COVID-19, SARS-Cov-2 Infection.
32756371 2020. BCG Vaccination and Mortality of COVID-19 across 173 Countries: An Ecological Study.
32758689 2020. SARS-CoV-2 clearance in COVID-19 patients with Novaferon treatment: A randomized, open-label, parallel-group trial.
32756480 2020. COVID-19: The Immune Responses and Clinical Therapy Candidates.
32766115 2020. Enlightenment from clinical trials on Chinese medicine for coronavirus disease 2019 (COVID-19).
32766114 2020. Home-based traditional Chinese medicine nursing interventions for discharged patients with COVID-19: a rapid review of Chinese guidelines.
32766113 2020. The role of Korean Medicine in the post-COVID-19 era: an online panel discussion part 1 - Clinical research.
32766112 2020. Evidence map on the contributions of traditional, complementary and integrative medicines for health care in times of COVID-19.
32742920 2020. Could herbal medicine (Soshihotang) be a new treatment option for COVID-19?: a narrative review.
32742919 2020. Is the traditional Chinese herb "Artemisia annua" possible to fight against COVID-19?
32738617 2020. ACE2 Co-evolutionary Pattern Suggests Targets for Pharmaceutical Intervention in the COVID-19 Pandemic.
32713863 2020. Computational search for potential COVID-19 drugs from FDAapproved drugs and small molecules of natural origin identifies several anti-virals and plant products.
32764200 2020. Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population.
32678432 2020. Blocking inflammation on the way: Rationale for CXCR2 antagonists for the treatment of COVID-19.
32754463 2020. Preventive and treatment strategies of COVID-19: From community to clinical trials.
32627758 2020. Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2- Specific Immune Responses.
32658285 2020. Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic.
32758429 2020. Vitamin D for COVID-19: a case to answer?
32750438 2020. The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19.
32759013 2020. High dose folic acid is a potential treatment for pulmonary hypertension, including when associated with COVID-19 pneumonia.
32758904 2020. N-acetycysteine: A potential therapeutic agent in COVID-19 infection.
32658853 2020. Uso de plasma de convalecientes para tratamiento de COVID-19. Historia y evidencia.
32752010 2020. Is Antioxidant Therapy a Useful Complementary Measure for Covid-19 Treatment? An Algorithm for Its Application.
32756215 2020. Therapeutic response to corticosteroids in a critically ill patient with COVID-19: A case report.
32769922 2020. A systematic review and meta-analysis of the efficacy and safety of western medicine routine treatment combined with Chinese herbal medicine in the treatment of COVID-19.
32729248 2020. In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression.
32751194 2020. Newcastle Disease Virus as a Vaccine Vector for SARS-CoV-2.
32721181 2020. Immunometabolic Status of COVID-19 Cancer Patients.
32639219 2020. Anti-protease Treatments Targeting Plasmin(ogen) and Neutrophil Elastase May Be Beneficial in Fighting COVID-19.
32741697 2020. Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review.
32756606 2020. Development and simulation of fully glycosylated molecular models of ACE2-Fc fusion proteins and their interaction with the SARS-CoV-2 spike protein binding domain.
32761523 2020. Potential treatment of COVID-19 by inhibitors of human dihydroorotate dehydrogenase.
32754890 2020. Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.
32759053 2020. A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavir.
32747923 2020. Ethical review of patient safety and public health in EU clinical trials legislation: impact of COVID-19 pandemic.
32761451 2020. Beneficial effects exerted by hydroxychloroquine in treating COVID-19 patients via protecting multiple organs.
32753646 2020. In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication.
32742241 2020. Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes.
32714112 2020. A SARS-CoV-2 Vaccination Strategy Focused on Population-Scale Immunity.
32748331 2020. Physiological Relevance of Angiotensin Converting Enzyme 2 As a Metabolic Linker and Therapeutic Implication of Mesenchymal Stem Cells in COVID-19 and Hypertension.
32746913 2020. Clinical practice guidelines and experts' consensuses of traditional Chinese herbal medicine for novel coronavirus (COVID-19): protocol of a systematic review.
32684095 2020. Worrying situation regarding the use of dexamethasone for COVID-19.
32662203 2020. Hypothetical targets and plausible drugs of coronavirus infection caused by SARS-CoV-2.
32713627 2020. Convalescent plasma for covid19 - How long should a donor be excluded from donation?
32711925 2020. Can Activation of NRF2 Be a Strategy against COVID-19?
32707833 2020. COVID-19: Mechanisms of Vaccination and Immunity.
32730781 2020. Immunometabolism pathways as the basis for innovative anti-viral strategies (INITIATE): A Marie Sklodowska-Curie innovative training network.
32726231 2020. Addendum to Systematic Review of Remdesivir for the Treatment of COVID-19.
32726230 2020. Remdesivir for the Treatment of COVID-19: A Systematic Review of the Literature.
32726238 2020. Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management.
32742564 2020. Stem cell therapy for COVID-19 and other respiratory diseases: Global trends of clinical trials.
32684209 2020. [Meta-analysis of single-group rate of the distribution of traditional Chinese medicine syndromes in 2 139 patients with coronavirus disease 2019].
32684206 2020. [Application of convalescent plasma for the treatment of adult patients with coronavirus disease 2019].
32684205 2020. [Expert opinion on diagnosis and treatment of coronavirus disease 2019 with traditional Chinese medicine based on "three syndromes and three methods"].